Content-Type: text/html

Reference sequence (query): batch____
Identities normalised by aligned length.
Colored by: property
HSP processing: ranked
Search cycle: 2
                                                                                                      1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .] 181
    batch____                                              bits   E-value  N 100.0%   1:181             MMILVTGGARSGKSRHAEALIGDSSQVLYIATSQILDDEMAARIEHHRQGRPEHWRTVERWQHLDELIHADINPNEVVLLECVTTMVTNLLFDYGGDKDPDEWDYQAMEQAINAEIQSLIAACQRCPAKVVLVTNEVGMGIVPESRLARHFRDIAGRVNQQLAAAANEVWLVVSGIGVKIK    
  1 UniRef50_P0AE77        Adenosylcobinamide-phosphat...   245     7e-64  1 100.0%   1:181   1:181     MMILVTGGARSGKSRHAEALIGDSSQVLYIATSQILDDEMAARIEHHRQGRPEHWRTVERWQHLDELIHADINPNEVVLLECVTTMVTNLLFDYGGDKDPDEWDYQAMEQAINAEIQSLIAACQRCPAKVVLVTNEVGMGIVPESRLARHFRDIAGRVNQQLAAAANEVWLVVSGIGVKIK    
  2 UniRef50_A6TU77        Adenosylcobinamide-phosphat...   222     3e-57  1  47.2%   2:181   6:187     -LVLVTGGARSGKSSFGESLLReqGNILYIATAQAFDEEMKERIKHHKIQRPSHWMTHEGYENLGPVISVLGGQIEGVLLDCVTIMVTNLMFqeSNWDEVGTERIHQVENHIQAEVKTLLDTVKGLEIPVIFITNEIGMGIVPENKLARIFRDIAGRVNQMIAKEADQVYLVTCGISQRIK    
  3 UniRef50_A0Q0J9        Cobinamide kinase n=4 Tax=C...   220     2e-56  1  43.9%   2:181   4:186     -IILVTGGARSGKSSYAENIAKNVGEKiyIATSIPFDEEMKHRVKKHKESRPEIWDTYEGYKSLDKVVREKNNLYDGMLLDCVTIMTSNFMFDYIGdeEADNTTLDTVEKKIITNFEKLLNEAIKGNSTMILVTNELGYGIVPENKLARVYRDIVGRINQYIASRASEVYLVVCGIPIKVK    
  4 UniRef50_Q3A797        Adenosylcobinamide kinase n...   219     3e-56  1  39.4%   2:181   4:178     -MILITGGARSGKSAFAQNLAEapGPHAYVATCPVTDPEMAERIAKHQKARARhwQTIEEPLDLPAAL-AQAQNFPTVLVDCLTLWINNLMYQAAG------KNQSLSEDDVQLRCQALTEAVQRHPGTVIFVSGEVGLGIVPENRETRLFRDLLGRCNQLLAASAQQVTLVACGLPLHLK    
  5 UniRef50_C9XS27        Bifunctional adenosylcobala...   219     4e-56  1  43.3%   2:181  22:203     -IILVTGGARSGKSNFAEKLCFDRNNNtyIATSIPFDDEMKDRVKKHQENRPRNWNTYEIYEDIYSIIKEIYKEHETVILDCVTLLVNNLMFEHNLneESSQEEINKLEQYIKEQVVKLIEEIEKTNLYFVFVTNELGMGIVPGNKLSRIYADIVGRINQYIASKSNEVYFVVSGIAMKIK    
  6 UniRef50_A5I0A2        Bifunctional cobalamin bios...   217     1e-55  1  41.1%   2:181   7:185     -VVLITGGVRSGKSEFAESLLQKEKSVLYIATAKITDKEMEHRVEKHKERRNSEWKTYEGYKDLGKIIKYHNEKN--ILLDCVTIMTTNLMFHKEIdeNIKEEELDEILEGIKKEFHDLIISVKEENKNIILVTNEVGYSIVPAYKLGRIFRDFQGIINKFIASLSDEVYLVTCGIPLKIK    
  7 UniRef50_A4J5S8        Adenosylcobinamide kinase n...   217     1e-55  1  38.9%   2:181   6:183     -LILVLGGTRSGKSQYAEKIAkqGQRVLYLATATVNDNEMKRRVRLHQERRPDAWDTREEPIKVTQVINELGDSYDVILLDCLTLWITNLLLE---NQNINEAHLAEKEKQILQEASELALVCSKTNATVIVVSNEVGLSIVPEYPLGRVFRDISGLANQIFAQRASEVYFVAAGLPLSLK    
  8 UniRef50_C0GDW2        Adenosylcobinamide-phosphat...   216     3e-55  1  42.2%   2:181   9:188     -LVLILGGARSGKSKLAEEIALTSGevAYIATAPVYDQEMAHRVKLHKERRPDHWFTVEEPRDLTAALAAVPAETKTVLLDCLTLWLTNVLLA-DYDEDMPSEKIDGIEETIREELSRFCVAARKKNIRILMVANEVGCGIVPESRLGRLFRDIAGRANQQVAKEADAVYLAVAGYPLQVK    
  9 UniRef50_A5TUY8        Adenosylcobinamide kinase n...   216     3e-55  1  39.4%   2:181   4:187     -IIFFTGGSRSGKSKFAEEYisHYKNKIYFATAIAFDEEMQDRIERHVKRRGNTWKTVEGYKNLVSLIKNDIDEADVILFDCVTNFVSniMDREIDWDNVDLSLVHEIEDKIEEETINFLEFVKSKKCDCVFVTNEIGSGLVPDYPLGRYFRDICGRINQLIAKNSDEAYLAVSGIKVKIK    
 10 UniRef50_Q0K7I3        Adenosylcobinamide-phosphat...   216     3e-55  1  40.0%   2:181  53:239     -LTLVLGGARSGKSHYAEQLATdgGPVTYIATAHQddQELEVRIALHRARRPADWRLVEEPVHLADALYANARHDGCILVDCMTLWMNNLIFPDGRAYP--EHGVITPPDAFTEEIEALLTALPTLPGHVILVSNEIGFGVIPMGAITRFYVDELGRLNQKLAAAADCVRLMVAGIPVAVK    
 11 UniRef50_D0Z8S6        Adenosylcobinamide kinase/a...   215     5e-55  1  57.8%   2:181   1:181     -MILVTGGARSGKSAHVERLAAqcERILYIATASVTDDEMAARIAQHRAQRPSHWRTWEGYRDLGEVIRHQVRPGEGVVLECITTMLANLLYEASGGASPETLDFPALEAVLQRQVDDLIAACQQSAAPVFIVTNELGMSITPENRLARHFVDIAGRANQRLAQAAQAVWLVVSGIGVQIK    
 12 UniRef50_B8DC85        Bifunctional adenosylcobala...   214     8e-55  1  42.8%   2:181   4:185     -MMLVTGGARSGKSNFAEKEAAKYNRVLYVATGIAydTEFQARIQKHQATRPANWDTFESFQGIAAYLDQHTNEYELIMLDCVTMLVTNLFFTMLGERELTNEVADEVEAAIQLEVAAILTAGKKSSAKLIFVTNEIGLGVVPENKLTRVFRDIIGRINQQIATQVEAVYFVVSGIPKRWK    
 13 UniRef50_A4C9U1        Bifunctional adenosylcobala...   214     9e-55  1  36.5%   1:181   1:186     MKHLIIGGVRSGKSRYAECLAssSKPVLYLATAEPIDAEMQARIAHHQAHRPSTWPTIEAPLKLEPILLNPNYQQHLILIDCMTLWLNNWLyeYKGLEAIVLSESEYVNNSFQQVKSDFLGALKNTQADVVLVSNEVGFSITPENALARQFCDQQGWLNQAIAEQCEQVSAVMAGLPLLLK    
 14 UniRef50_A3DK67        Adenosylcobinamide kinase n...   214     1e-54  1  43.9%   2:181   4:187     -FILVTGGARSGKSSFAESLVKECGnvLYIATSIPFDEEMKKRVKKHKERRPSGWTTLEAYRDFDIKLDKAGAGKKYILLDCITIMVSNIILEKCIDWNILPENadEAEMEAVREVEKLLCAVKALNVTFIAVTNEVGMGIVPGNRLSRVFQDIAGRVNQMLAKNADEVYFCVSGIPVRIK    
 15 UniRef50_B3E974        Adenosylcobinamide kinase n...   214     1e-54  1  40.8%   3:181   5:177     --TLITGGARSGKSRFAEELTRSFGplCYLATAQPLDDEMGERIHRHQLRRGTAWETLEEPLMIPQTLARIDGIYSAILLDCVTLWLSNLLLSCD-------ENDPGCEEQVLSHVHRLAGTLRGMSTPVVLVTNEVGQGIVPENRLGRLYRDIAGQANQLLAAGCDAVYVTISGIPLKLK    
 16 UniRef50_Q3BQB6        Adenosyl cobinamide kinase ...   214     1e-54  1  38.7%   1:181   1:169     MQQLILGGARSGKSALAERIAAGSGrvTYLATAQAFDGEMHRRIAHHRSERPAHWQCVEEPIALAATLQAHAAPDRCVLVDCLTLWLSNLLGHPDA-------------GMFARERDALLATLPQLPGQILLVSNEVGQGIVPLGKLTRRFVDEAGWLHQALALQCERVVLVVAGLPMVLK    
 17 UniRef50_B9QU56        Cobinamide kinase / cobinam...   213     1e-54  1  39.1%   3:181  10:174     --TLVFGGARSGKSTFAERLAARSseRVYVATGAAFDDEMADRIALHKDQRGSYWITIEEQLDLAGVLSRESAAHRVILVDCLTLWLSNLMFSD---------------KDIAEETARLIEATKGLAGPCVFVSNEVGMGIVPENRLSRSFRDAQGRLNQDIASACHQVVFVAAGQPLLLK    
 18 UniRef50_Q2RJI8        Adenosylcobinamide kinase n...   213     2e-54  1  40.0%   2:181   6:186     -LIMVTGGSRSGKSSLAEKLAGegGQVVYLATAMINDEEMAARVDLHRNRRPASWRTIETPLEVIETIRQEGRQADTLLLDSLGMWLSNLLNNYHYEAEKNREQREELIARITSRFRELATTAYQVRARVIVVTEEVGLGLVPPYPLGRLFRDLLGLANQELARQADRVYLVVAGLPVVLK    
 19 UniRef50_A0LLI4        Adenosylcobinamide kinase n...   213     2e-54  1  38.5%   3:181  11:177     --HLVLGGARSGKSFYAeqIAGFASPYVYVATARVLDAEMSERVGKHRERRGPAWETIECPCDLTATLKLLRERNRPVLVDCLTLWLTNLIL-------------GSSQEASEQSIEELCEFLRGANYPLVLVANEVGFGIVPDNPLARRFRDLAGLANQRVAAECAAVTLVVAGIPLPLK    
 20 UniRef50_C9R917        Adenosylcobinamide-phosphat...   212     4e-54  1  42.8%   2:181 113:279     -LILVTGGVRSGKSRFAESLLREEPEVFYLATAVITDAEMEERIKAHRSRRPHHWHTLEEPEELVRALEQV-PSDRALLLDCLGIWVSNLLVAGRG------------EKEIEQQARELVAALRQREGRTVVVTNEVGMGLVPTSALGRIYRDLLGNINQILAQAADMVYLVVCGLPMQIK    
 21 UniRef50_A5N653        CobU n=2 Tax=Clostridium kl...   212     6e-54  1  40.0%   2:181   4:185     -LILVTGGARSGKSSYAERLAKerGDILYVATSIPFDDEMKFKVKKHIEQRPSNWDTLEAYKDFHSKLIPMLPGKSGVILDCITNLVSNLLLecGDIEKIKASQIVEIEEYIKGEIKEFINISKNTSIPFIVVTNEVGMALVPEYKLGRIFRELAGSVNQIIAKEAEKVYFCISGIPVRIK    
 22 UniRef50_B8G2F4        Adenosylcobinamide kinase n...   211     9e-54  1  41.1%   2:181   4:189     -FVLITGGARSGKSRFAELLAAHPgpVTYIATAQVYDEEMALRVKKHQDQRPAHWGLVEEPLALSSVLERHAQNKGVLLVDCVTLWLTNLLLAHYPAEDHLTEqlHRLEQKILEQVRIVARIARDITPQVIMVTNEVGDGIVPDNPLSRIYRDLAGRANQILGQSAQQVYSVVAGYPTEIK    
 23 UniRef50_P29931        Adenosylcobinamide-phosphat...   210     1e-53  1  41.9%   3:181   9:173     --VLVLGGARSGKSSFSERLVEASgtMHYVATGRAWDDEMRERIDHHRTRRGEGWTTHEEPLDLVGILRRIDDPSHVVLIDCLTLWVTNLMLE---------------ERDMTAEFAALVAYLPEARARLVFVSNEVGLGIVPENRMAREFRDHAGRLHQIVAEKSAEVYFVAAGLPLKMK    
 24 UniRef50_Q3IK34        Bifunctional adenosylcobala...   210     1e-53  1  36.0%   4:181   7:172     ---LILGGARSGKSRFAEQLAMKSNkvIYLATAQPNDDEMQVRITRHQKDRPANWQLVEEPIALAKLLKAHSKADNCILVDCLTLWLTNCLCHSD-------------KHCWQTQKAELLAQLKSLPGQVIFVSNEVGHGIVPLGELSRTFVDESGWLHQALAAQVSQVEFIMAGLALTLK    
 25 UniRef50_A4WPS3        Adenosylcobinamide kinase n...   210     2e-53  1  41.7%   2:181  12:176     -LTLVLGGARSGKSRMAERLVIGSGrrFYLATAEAWDDEMRERISAHRHDRGDGWQTVEEPRDLSPVLSRMPPEA-CVLLDCATLWLTNHLLAD---------------SDLDAAIASLLHALDACPAPVVVVSNEVGWSIVPENSLARRFRDEQGRLNQRLAGQADLVVAAMAGLPMVLK    
 26 UniRef50_Q47XZ5        Bifunctional cobalamin bios...   209     4e-53  1  35.4%   1:181   1:182     MIHLVLGGARSGKSRFAEQqvKQGKQAVYIATATAIDPEMDNRIAQHQSDRGasWQLIECPLALAETL-SDLDNNNVYLLDCLTLWLNNQLYAVH------EENRGQQSQHLQTEIDKLATGLASVNADIIIVSNEIGLGVIPMGESTRLYVDYCGWLNQKVAEVSDKVTLVTAGIPLCIK    
 27 UniRef50_Q7MLF1        Adenosyl cobinamide kinase/...   209     4e-53  1  38.8%   4:181  11:183     ---LVLGGARSGKSRFAEQLVRQWskCHYVATAVPFDQEMAERIHHHQQQRGQGWCEHEVPLHLAERL-SLFGADDVVLVDCLTVWLNNWLFEFGE---------QASNEKLEQKVAQLVSVVKESTAQIILVSNEVGLGVVPLGQISRLFVDNAGRMNQSLAQACDNVTLIAAGLPLILK    
 28 UniRef50_B4SH91        Adenosylcobinamide-phosphat...   208     6e-53  1  40.0%   2:181   9:178     -IYYVTGGARSGKSSFALQLAKPYYSRVFLATAEPFDGEMVQRISKHREERGEQFTTVEEPLALDRALLHLPEGTDVVLLDCLTVWTGNLMHYGEG----------KGEGEIDQQIERFLEVLRHPPCDMILVSNEVGMGIVPENAMARRFRDIAGIINQRVAALATEAWLLCSGLPIRLK    
 29 UniRef50_C6D296        Adenosylcobinamide-phosphat...   208     7e-53  1  40.9%   1:181   1:191     MAMLVTGGARSGKSSFAEKLAARLGEqvYIATSRIWDEEMAERIALHQQNrgFRWTTIEEPVGLSGRLRQLAKEapVILVDCLTLWLTNVLMEAEEREKSESMEKD----WLSEQVNELAAAVQEYNYPLILVTNEVGDGIVPAYPLGRRFRDEAGRLNQRMAALSDKVFLVTAGIPVELK    
 30 UniRef50_Q73K40        Cobinamide kinase/cobinamid...   207     2e-52  1  39.2%   1:181   1:178     MITLITGGSRSGKSAYAEKLLDGINDVVYIATAEIYDDEMQERVKRHIKRRNPKWRTYEGFLNLEKAVN----GEKYYLLDCITNLISRILFQITGEKepSEEEIQKTIDTSLTQIKNLILEIKKINGSLILVTNEVGSSIVPMHPVSRAFSDIQGIVNAKIAELADEVVLCVCGLPIKIK    
 31 UniRef50_A8MIW3        Adenosylcobinamide-phosphat...   206     2e-52  1  46.7%   2:181   4:186     -FILITGGARSGKSRFAEKMAAEQgkVVYIATAIAFDEGMKDRIKKHQQDRPQIWKTIERYKDFNALKerAFIESDCILLDCVTLMVTNLILESNLDFDnsMEDIDVLEQGIFKEIEILLDITAHHHKDAIIVTNEVGMGLVPAYRMGNIFRDIAGRVNQYIAGRADEVYLTVSGIEMKIK    
 32 UniRef50_Q3JUZ3        Cobinamide kinase n=93 Tax=...   206     3e-52  1  40.6%   2:181 529:701     -LTFVLGGARSGKSAHAERLAAAGGrvTYIATARVADDEFAERIAHHRARRPADWALVEAPVELAPALARLDDANACVLVDCLTLWLTNLLCPADGPGVDD--------ARCDAYVAELEAALRASRARVIVVSNEIGFGVVPLGRQTRRFVDTLGRVNQRIAALATRVTVCVAGLPVTVK    
 33 UniRef50_C1TM08        Adenosyl cobinamide kinase/...   205     8e-52  1  42.8%   2:181   4:189     -IILVLGGARSGKSGFAQSLISDQEriFYVATAGIEDDEMARRVARHRADRPDRWKTLEAQNDVVGTLEE-IPSKSIVLLDCVTMMVTNLMfrRTEWDGLSMEDERLVEQFVLGEVDRMLEVFRRRDLSAVLVSNEVGQGLVPPYPLGRIFRDIAGWANQRIAKEADSVYLITAGIPQIIK    
 34 UniRef50_A6WJZ3        Cobalbumin biosynthesis pro...   203     2e-51  1  39.8%   1:181   1:204     MIHLVLGGARSGKSRYGEALVRQYTAlcYVATAQALDDEMATRIAKHQAGRTDdwQLFEESLALTALLKRLAKPGRVILVDCLTLWLTNQLLASSAKIDDEPasNDEALASWQAEKTAFVDSLAELEGVVVLISNEVGSGIVPLGELSRQFVDEAGWLNQAVAALADNVTLVVAGLPLALK    
 35 UniRef50_A1B2C4        Adenosylcobinamide kinase n...   203     3e-51  1  38.9%   2:181   7:171     -ITLVTGGARSGKSALAETIAahEGARIYIATAEARDDEMTQRIGLHRDRRGSGWRTVEEPRDLAGALAR-TDGQGARLVDCLTLWLSNLMADGDDPGP---------------RVRRLCEVLGTQDSPVVLVTNELGLGIVPENALARRFRDEHGWMNQAVARVADEVWMAVSGLPLCLK    
 36 UniRef50_B2IG78        Cobalbumin biosynthesis pro...   202     4e-51  1  36.0%   4:181  13:176     ---FILGGARSGKSFYAQRLAETSgrPVMIATAEAHDAEMAERIARHKSERGPLWGLVETPLALCETLEQNAHPASILLVDCATLWLSNLFFH---------------EAEIDTAVANLTATILKLSGPLIIVSNEVGQGIVPDNALARKFRDAQGRLNQALAQVCEGVVLVSAGLPLTLK    
 37 UniRef50_Q1MZQ8        Adenosylcobinamide kinase n...   202     4e-51  1  35.0%   2:181   4:170     -IHLVLGGARSGKSAYSEQLALGSKdlHYIATAQAFDDEMQTRIQRHQADRSARFHTLEEPIELSRRISELSVPGHTIVVDCLTLWMSNLLM--------------CEPENMATRSQTLIDALKSSKGRVILVSNEISMGVIPLGESNRRFVDELGRLHQGIAREAQHVTLMVAGIPSVIK    
 38 UniRef50_Q1JZW1        Cobalbumin biosynthesis enz...   202     5e-51  1  41.2%   5:181   9:180     ----ISGGARSGKSRYAEQRALaaGPRSYIATCPIIDDEMATRIDRHRQRrgQGWHTIEEPQDLTAALQTTRD-SRVVLVDCITLWINNLLYAAETELNTID------EGAIQALTLQMIDAARQGERTVIFVSNELGMGIVPAETLSRHYRDLVGRCNQTLAAHADEAVFMVSGLPLTLK    
 39 UniRef50_B2A0G1        Adenosylcobinamide-phosphat...   202     6e-51  1  40.6%   2:181   4:193     -LVLITGGSASGKSYYAEQLASQLEsvIYVATSRVEDQEMSQRVLKHKNRRPEHWDTVVAPKLNWEDINQIVQKNQIVLIDSISMYLSNNLLDFIGSNDPDNLDASCMEKFikAQMDELCNLFLQGTATVITVSDEVGWGLVPAHKMGRLYRDLVGRMNQILAQKAQEVSLVVSGIPTRIK    
 40 UniRef50_D2MJU3        Cobinamide kinase/cobinamid...   202     7e-51  1  37.2%   2:181  10:177     -LCFVLGGARSGKSRLALTLAGNALPRAFVATAEPGDEEMAARIRQHREDRDPTWETQEIPIDVSGWLKSKGVLYKTVVIDCLTLWLANLLGSGI------------QESKVLSSIDELMQSARTVPGSVVLVSNEVGLGIVPGDAVTRQFRDLAGAMNQRVAAASDAVYLSVSGLPMQLK    
 41 UniRef50_A8FZR3        Cobalbumin biosynthesis enz...   201     1e-50  1  38.1%   1:181   1:197     MIHLVLGGARSGKTRYATdlSAQGYECIYIATAQALDEEMISRIARHRQDRTEdwITVETPLLLAESLAQYARKNRVIIVDCMTLWLTNRLFANEPPTDSDYEQDRAEekSWPEAKAALLELLPTLAGEIYLVSNEVGCGIVPLGELNRRFVDEAGWLHQEIAKLADSVVLVTAGLPMRLK    
 42 UniRef50_A6CZ11        Adenosylcobinamide kinase/a...   200     2e-50  1  39.9%   4:181   5:178     ---LIIGGARSGKSSFAENraSEGLTKHYVATSESIDNEMRARIEHHRRQRGLGWREWECPLALVEQLSTFSS-SDVVLIDCLTLWLNNHLFHLGDDCDDLG---------LMREIETLVKALAQCDAHVIVVSNEVGLGVVPMGEVSRLFVDNGGRMNQQIAKIAEKVVFVAAGLPLVLK    
 43 UniRef50_C7NEM2        Cobalbumin biosynthesis pro...   200     2e-50  1  36.1%   2:181   3:196     -LIFVTGGAKSGKSKFAEELIlgKQENVYLATSLVFDEEMKEKVRLHKERRKNNWGTVETYKNFENSLNEYFPkkNNMLVDCLTTMITNIIFEevDWDNFDKKSYVKIVEKLDKNVENTVNEltNQFENTIIVSNELGLGLVPSYPLGRYFREIAGKMNQAVAKRADEVYFVVSGIPMKIK    
 44 UniRef50_Q15WS5        Adenosylcobinamide kinase n...   200     2e-50  1  31.5%   1:181   1:180     MLHLIIGGARSGKSNFALQQaqSGKNVTFVATATATDTEMSKRIMRHQQERPAHWALAEVPLNLTEYIELYSDKgpILLIDCLTLWLNNQLYH-------------QPQQDFSILFQGFTQALRASESSIIMVANEVGLGVIPMGEVTREFVDQAGWLNQAVASIADHVTFVAAGLPMALK    
 45 UniRef50_D1BMH9        Cobalbumin biosynthesis pro...   199     3e-50  1  39.4%   2:181   5:184     -IILCSGGARSGKSEFAERLaaTKGPKAYVATGQAFDEEMVDRIKKHQERRGKIWNNFEVPLHLADEWENISQSADVILIDCLTMFTTNHMMAHGSIRG--QEDANRLEQTILSELDTLLDSIQSCEgtVIFVTNEIGLGIVPDNKLARYFRDIAGRVNRAVASVADKLYLTISGVTIELK    
 46 UniRef50_Q67N30        Cobinamide kinase and guany...   198     6e-50  1  41.7%   2:181   4:175     -VILVLGGARSGKSRWAEHLASPFRRVVYLATGRAGDAEMADRIARHRASRPAHWRTVEEELRPAAALAqhEAPADAVLLDCVTLLISNHLLQGE----------EGFEARARQELAQLLSLTRERGALLIAVSNEVGAGLVPEHRLGRLFRDAQGRLNQWLAREADQVYACVAGIAVDLR    
 47 UniRef50_A3QAU0        Adenosylcobinamide kinase n...   198     9e-50  1  37.0%   1:181   1:173     MMHLVLGGARSGKSRHGLSLVADYVARGyvATAQGLDEEMRARIARHQDErgLSWQTLECPLHLSACIETHAREKRVILVDCLTLWLTNQLLEGDDWPLARAALLRALE---------------TAPGAVVLISNEVGCGVVPADPLSRRFVDEAGWLHQAIAQRAQQVVLVTAGLPLILK    
 48 UniRef50_Q6ALU3        Related to bifunctional cob...   198     9e-50  1  36.1%   2:181   4:179     -LILVTGGSRSGKSSFALDLakKSERRIFVATCPVVDGELTERVRLHKEErgRGWTTCEEELDLARAIATSNGEDGVVLIDCLTLWINNLMFFHEQDG------KAFSTEQLRKQCQFFLAEVELLSGTVICVTNEVGLGIVPDNALARRYRDLVGICNQLIAENASEVYLVTCGISQQIK    
 49 UniRef50_D0D9A3        Bifunctional adenosylcobala...   197     1e-49  1  43.0%   3:181  26:189     --ILITGGVRSGKSREAERmlALGQPAIYIATAEAHDDEMADRIARHQARRGPEWRTVGAPLDLAGAL-RDSDGTAPRLVDCLTLWLTNLMLSG---------------RDWEAETRRLTALLPELRAPVVFVTNEVGAGIVPENKLARDFRDAAGLVNQQIAAACDELWFCVAGHPMKVK    
 50 UniRef50_A1WY55        Adenosylcobinamide kinase n...   197     1e-49  1  38.7%   1:181   1:178     MRELILGGVRSGKSRHAEQRASasDDVVYIATAQSRDDrmAERIAAHRARRPAHWRTVEAPLDLAEAIHAHDASGRVLLVDCLTLWLTNRLVAEDQAAGPPP-----SHETLEQARSDLVGAVSAAHGHLLLVSNETGLGVMPMNALARRFCDEAGALHQQMAECCERVTWTVAGLAQPLK    
 51 UniRef50_C4V0Y8        Adenosylcobinamide-phosphat...   197     1e-49  1  41.7%   2:181   4:184     -IILVTGGVRSGKSSFAERCAasGTAVAYIATAQIYDAEMQLRVDLHQSRRPADWTTYEAPFSSENAIREAGATHGVILFDCVTMFLSNDMLQY----SEEEQERDSFARHVEARINALIRAAEEADATTIFVTNEVGDGIVPANRLGRLYRDMAGLANQQLARRAAKVYLVTCGIPVDLK    
 52 UniRef50_C0F0E6        Putative uncharacterized pr...   197     1e-49  1  37.2%   2:181   4:185     -VIMVTGGSRSGKSVIAEQKAKEYGkvLYLATAIPIDDDMKERIRMHQERRDPEWGTYEGYRDLGEVVKNT--EKNTILLDCVTVMITNILFEEEERDFDkaSEVEKLESEVIKELTNLVKAIRDEDKTLIIVSNEVGMSIVPSYRLGRIFSDISGKANQVLASLSDEVYVAISGLPLRLK    
 53 UniRef50_D1YAS5        Nicotinate-nucleotide--dime...   197     2e-49  1  34.8%   3:180 380:554     --MLVIGGARSGKSTFAESRLPRDSRVTYVATSqpGDAEWEERIRLHQARRPATWQTVET-TDIASVL--LADDDSPVLVDCLGVWITRILDEVGAWAAAPG--DEAWQDDLRRHVDDLTSAIRGTRRDVIFVSNEVGMGVVPDTPAGRLFRDELGRLNAAVGEACDEVWMCVAGIPKRW-    
 54 UniRef50_B1I4H0        Cobalbumin biosynthesis enz...   197     2e-49  1  37.2%   2:181   5:184     -IVLVLGGAKSGKSRFAVDIarKSGRVLFVATAEPGDPEMRARIEAHRRERPADWCLLEAPLRVGQSLAGHLDGVRTVIVDCLSMLVANIILS-GQAVTFSGLEPDAGLEAVRREIEEIVRILSNYRVCCVVVSNEVGMGIVPDNALARRYRDALGLANQLLAREAEEVFLMVAGVPLQIK    
 55 UniRef50_A6UAB6        Adenosylcobinamide kinase n...   196     2e-49  1  34.6%   3:181   9:174     --TLVLGGARSGKSSFAEKRVETFgpMHYLATGRAFDQEMRERIVLHQAArgKGWTTHEEPLELVGLLRRINDPGRAVLIDCLTLWVTNLMMEERDMDAEFAALAAFLPEA---------------RSRLVFVSNEVGLGIVPDNRMARDFRDHSGRLHQIVAEKSAEVYFVAAGLPLKMK    
 56 UniRef50_Q0BUE8        Adenosylcobinamide kinase n...   196     3e-49  1  41.9%   3:181  88:250     --TLIIGGARSGKSRHAEALITspSPWRYIATAQAFDAEMRTRIEAHRAARVAGWETVEAPLDIATALIEH--PARPVLVDCLTLWLSNLILG---------------EHDLPAAMEALENALARRSACTILVANEVGLGIVPDNALARRFRDEAGLLNQRIAAGAGRVLLIAAGCALPLK    
 57 UniRef50_A3CL82        Adenosylcobinamide kinase /...   196     3e-49  1  39.4%   2:181   4:194     -IVLVTGGARSGKSAFAEEQLADRERVCYIATGLPrdPEWQERIRLHQERRPASWTTQEQYAGLADWLREQSHP--VYLLDCATLLTSNRLFDLIAQHFPDKLELTEEHFLSRQewQELLSAIHQTDAECWIVTDEVGLGIVPETRLGRFFRDVQGKINQLIAKEASEAYLVICGLAQQLK    
 58 UniRef50_A8ZY28        Adenosylcobinamide-phosphat...   195     7e-49  1  42.8%   2:181   5:175     -IILVTGGCRSGKSSHALELARRygERLFLATCVAEDDEMRDRVSRHQKERGRGFTTVECPVHLDREIVRAGRTASVILVDCLTLWTSNLMMEDG-----------FSPASAEDHVRSLEAAMTRVPCSVLLVTNEVGCGIVPENRLAREFRDLVGMVNRRVAARADTVVWMVSGIPVVLK    
 59 UniRef50_C1D6G5        CobU n=2 Tax=Neisseriaceae ...   195     7e-49  1  36.5%   1:181   1:167     MLHLITGGARSGKSSHAEQLaaHAGPIHYLATAAVGDAEMAHRVVMHQARRPVHWRVIECGAGLPAALEDAARPDGLVLVDCLTLWLVHFL---------------EQPAAFMAARQTLLDTLAGVPGDVLLVSNEIGCGVVPLGEDNRWFVDELGRLNQDIGALADRVTLLVAGQPLAIK    
 60 UniRef50_A1TXA5        Adenosylcobinamide kinase n...   195     8e-49  1  33.7%   4:181   6:173     ---LVTGGIRSGKTGLAEQRAKATGnvVYVATATAGDDEMALRIQRHQELRPDHWQLAEEPLRLGQVLSEYAsePPLLLVDCMSLWLSNLLFADG--------------ALFQPERAAFLEAVEVYPGSLVIVTNEVGLGTIGMDPLTRRFTDELGWLNQALAQRCDEVVMAVAGLPLTLK    
 61 UniRef50_A5D2P4        Adenosyl cobinamide kinase/...   195     8e-49  1  39.4%   2:181   5:181     -LILTLGGSRSGKSEFAEKIAGlgERVVYIATAAVLDGEMAERVRLHRARRPLTWETVEEEKNILDVLER-GREGDVFLIDCAAVWITNLLLDRDLPRPGAGW--GEKEVYITEQLNSLADAVKKG-VHLVIVSSEAGMGIVPEHPFGRLFRDVLGKANQLLAAKADRVFFVVAGLPLELK    
 62 UniRef50_UPI0001BC5365 cobinamide kinase n=2 Tax=F...   194     1e-48  1  36.1%   2:181   4:188     -IVYFTGGARSGKSAHSEQYirHYDHKIYLATAVVFDEEMKERVKLHVERRGKEWDTLEGYRNLYNLVKSSMKerGVILLDCITNMVSNVLLEeeDWENISQERIQELEKCILEEISTFLEEIKKTSYDLVVVSNELGMGLVPPYPLGRYFRDICGRANQLVAEEAQESYFIVSGTKLRLK    
 63 UniRef50_D2BHE7        Cobinamide kinase/cobinamid...   193     2e-48  1  35.9%   1:181   1:184     MNYLLIGGARSGKSSYAEELAKsgGNIVFVATAEAGDDEMKTRILRHQQARPPEWRLIEASLGVGEKISAYRENADVIILDCITLLVNNIMCQYMLEHGdtGDAADYLDTAVKKEINDIILAMEKTGASFIVVTNDVGAGLIPPNAMARVYRDLLGRANQMLGAYVEYIYLMVAGLPMQVK    
 64 UniRef50_A6DF36        Bifunctional cobalamin bios...   193     2e-48  1  36.7%   2:181   4:177     -ITFITGGCRSGKSSKAEELCLNSPPPhyLATATAFDGEMSKRIEAHKIQRAahWNNVEEPLEILEKIKDF--KEGSVLLECVTLWISNLM------WQSEQDNAEINESLIIEKTEALIEAMKVSPCHFFIVSNETGLGIMPMNAQARLFGDLAGRCNQLLAKAADRAIFMVSGLPMELK    
 65 UniRef50_C9L8S5        Cobinamide kinase/cobinamid...   192     6e-48  1  32.0%   1:181   1:170     MITLITGGSGSGKSAYAEQKVVEFgnRIYIATMYPFDEESHQRIARHRAMRakNFSTVECYVGLKNV---KIPKHSCVLLECLSNLTANEMFQENGAK-----------EKVVEEILEGVKNLDKQAEQVVIVTNEIFSDGIKYDEETKQYQKYLGEINARLAAWAKEVTEVVYGIPVQQK    
 66 UniRef50_Q04NE4        Bifunctional adenosylcobina...   192     6e-48  1  33.3%   2:181   4:181     -ITLITGGCRSGKSGLALKLANeqGKKYFVATCPAFDEETNQRILKHKKERelPWETIEEEFNLSNVFKPglSESSIVVIDCLSLWINNLLYQ------ANKKNSEIDETTIKKNCMELIHSIQNSEahVICVSNEVGLGLVPENKIGRIYRDLLGICNQSIAHNANFVYFMVSGIPLKIK    
 67 UniRef50_A6LIW7        Cobinamide kinase n=13 Tax=...   192     6e-48  1  38.3%   2:181   5:170     -VILVTGGQRSGKSGYAQRLALssPNPVYLATSRIWDEEFRKRVERHQRDRGPEWTNIEE----EKYLSRHDLTDRVVVIDCVTLWGTNFFFD-------NQSDVELSLSLLKAEFDKL----SRQDAYLIFVTNELGMGGVPIDEVQRKFTDMQGWLNQYIASKADEVVLMVSGIPVKIK    
 68 UniRef50_D1N4N2        Adenosylcobinamide-phosphat...   192     7e-48  1  38.3%   2:181   5:177     -LILVTGGARSGKSSFSERllENCRRPAYVATCPVLDAETAERIRLHRARREAgwITVEEETDLAAAFDRAEAArdGVLVDCLTLWINNLLYR----------NPEFSEQGMRETLAELLPRMRCFPGPAVLVLNEVGLGLVPETPLGRRFRDLSGRCGQLVAAEADELYFVVCGIPQRIK    
 69 UniRef50_C0Z7H5        Bifunctional adenosylcobala...   191     8e-48  1  43.3%   2:181   3:178     -LVLVTGGVRSGKSRYAEELAMTLgrVLYVATGKAWDDEMKQRIEQHQARRPLEWGCVEVGERLTDY-HAFREQYDVVLIDCLSTWVSNRLMSVE----ESEWRSASHTQALLQEAEAWLTLVQNSPQKVIAVTSEVGLGGVALSRLGRWFADVLGDVNQRSARQADAVYAVLSGIPWRIK    
 70 UniRef50_B5YL80        Bifunctional adenosylcobala...   191     9e-48  1  32.6%   1:181   1:169     MITFIIGGIKSGKSNFALKEGEKTGNryYIATARVIDEEMKERIERHKKERGSHWITIEEPINLNEAIMKITQNSSVV-IDCLTTWLTNLLVEGYDFCE------------FVEAFFDLLRKYRD-EIHLFIVANEVGLGIIPENELGRKFVDLAGTVNHKVMDICDRAYLMVAGVPLRIK    
 71 UniRef50_B2UM52        Cobalbumin biosynthesis pro...   191     1e-47  1  33.3%   2:181   1:180     -MTLVLGGIRSGKSQYAEQIAAGFGKKiyVATAEVWPGamEYRVRKHQERRPKSWLTLECPRHVASAVGESgdQVDGVILECVTLLSSNTLYAQ-----KDPTDYEPFQEALIEEIEALKKLIRQSPVPWVLVSSETGMGISQSDAETRHYCDGLGIANQLLAKSADEVYFMVAGLPLTVK    
 72 UniRef50_Q75NF4        Bifunctional cobalamin bios...   190     2e-47  1  39.3%   3:180  33:203     --TLVTGGARSGKSSYAEALLGSFDHVDYIATSqpDDPEWMARIAAHVARRPKSWNTVET-LDVAQVLSDDGSPA---LVDCLGVWLTRELDVTDAWQHP-----EQARPELQHRIDELATAVAGSPRRVVLVTNEVGSGVVPATQAGRTFRDWLGILNASVADACDEVLLCVAGRALSL-    
 73 UniRef50_A5VM64        Adenosylcobinamide kinase n...   189     3e-47  1  37.8%   2:181   6:196     -LTFVLGGAKSGKSEFAEHLYSRKERICYIATGVVkdGEMQLRIQRHQARRSNKWITREQYQHVDELIN--NSQQDGYLLDDAIMLVTNLFYDLVLAKTSPEKIDDYLESASSQEikKILAAVRVNNQSMVIVSDEVGLGVVPATKQTRILRDLYGEVNQLIAKEADNVYFVISGIAQKLK    
 74 UniRef50_A1KBG7        Cobinamide kinase/cobinamid...   189     5e-47  1  42.1%   4:181  21:196     ---LILGGARSGKSRHAEALAGASgaVTVIATAEGGDAEMSARIRRHQADRPAHWRTVEEPLALAAALRREADAGRCVIVDCLTLWLTNLL---AGAETLPPEAGADALPRFRAERDALLDVLPALPGEILLVANEVGLGLVPETPLGRLFRDEAGRLNQAIAARVPRVSFVAAGLPLRLK    
 75 UniRef50_C9LLC1        Adenosylcobalamin biosynthe...   188     6e-47  1  35.6%   2:181   5:190     -IFLVLGGSRSGKSEFAEELmsTGKRKGYVATSRILDDEMKYRVILHQKRRPEDWKTFEILGEVSGKIGFVLMEADTVLFDCITMYVNNILMEHLANKDNETldLTALQTLLEKDLELLFNIISQtnKEIIFVSDELGMGIVPANAMSRVYRDLVGLANQYVAQKADKVYLSIAGITVELK    
 76 UniRef50_B0TIK5        Bifunctional adenosylcobala...   188     6e-47  1  38.3%   2:181   8:188     -LVLVTGGARSGKSAWAEQLAAepEQVVYVATAGVFDEEMRRRVDTHRQRRPAAWQTVEEPLDLLRVIDEWDEEGRVILIDCLTL----WTTNLLLPQYREEEWNNQKEQTLVDMARHTAKRASASRATVIAVGNEVGWGIVPPDPLSRAFRDAAGRVQQAFATEAHRVYLAVAGCPLQVK    
 77 UniRef50_Q5LCE7        Bifunctional cobalamin bios...   188     7e-47  1  38.9%   2:181   4:169     -IILITGGARSGKSSHAERLALssPNPVYLATSRIWDEEFRQRVLRHQANRGPEWTNIEE----EKELSRHTLEGRVVLIDCVTLWCTNYFFDL-------EADTDKALTAVKAEFDRLT----QQDATFIFVTNEIGMGGTSENLIQRKFTDMQGWMNQYIASRANRVILMVSGIPVKVK    
 78 UniRef50_B8G7Z0        Adenosylcobinamide-phosphat...   188     9e-47  1  43.3%   2:181   4:173     -IILFTGGARSGKSRCAERYATrsEHVVYLATATADDDEMRLRIEHHRRRRPSTWRTVEATAHLATVLAEL-PAGTVVLLDC----------LSLLVSNLLLANESHPEPAINRELDDLLAMVDQRDLTLIAVTNEVGMGIVPAYPLGRQYRDLLGLANQRVAAAATAVYLVVCGIPVELR    
 79 UniRef50_Q1GJH8        Adenosylcobinamide kinase n...   188     1e-46  1  37.8%   2:181  39:203     -VTIILGGAASGKSAFAEQACVKTGkrVYWATSQIFDSEMQEKVARHVDQRGAGWTTIEEPYEAKTALGA-AQSQDVLLMDCATMWLTNHLLA---------------ENDLEKETRVLLEAIKDCPAEVVIVTNETGLGIVPENALARRFREAQGRLNIALAAAADTVVLVAAGLPMTLK    
 80 UniRef50_B0BZE0        Cobinamide kinase / cobinam...   187     1e-46  1  31.1%   2:181   6:173     -LVLVTGPARSGKSEWAENLAGQSNrvIYVATAapEDEEWQTRIQAHQQRRPTNWQTIHAPMDLAKTIQAQ-PKSICLLIDSLGTWLANILDQEA--------------ELWAVTLETLLKAMTQAECQIIVVGEETGWGVVPGYPLGRRFRDRMGELLRQIGAISDQVYLVSAGYALNLK    
 81 UniRef50_C5D3K1        Cobalbumin biosynthesis pro...   187     2e-46  1  33.1%   1:181   1:181     MIVFISGGVRSGKSRIAekLATPESSLHYIATARALDNEMKQRIDHHQKRrpMKWITWEQSVRLDKLI-PVFTKSDVVLLDCITNWLANELFADESWQKEANCFHKARQMWIV------LQQLEKACKALIIVSNELFSGGVPDDLGTYHFMKTLGWLHQQIVANAQIAILAQNGIAVVKK    
 82 UniRef50_Q16AZ7        Bifunctional adenosylcobala...   186     3e-46  1  36.1%   2:181   5:169     -LSLVLGGAASGKSLWAENHTLNSgePVYLATSRIFDDEIKIKINFHKKRRDHRWLNIEADAELQSALSQL-QPTQAVLIDCATMWLTNQMMD---------------EKDLQAAQADFLNAIRTCRAPVVVVSNEVGQGIVPDNAMARTFREAQGRLNIALADQADTVVLVTAGLPLVLK    
 83 UniRef50_Q1AYA6        Adenosylcobinamide kinase n...   185     5e-46  1  40.0%   2:181   5:185     -LVLLTGGARSGKSRHAEALASsgERVLYVATAGVGDREMRRRVEEHRRRRPPSWETLEARRDVASRLAGLGEPPPVVLLDCLSLLVSNALLDEAARCGEGPELEGAASRAVEEELSGLLGWHEAAGGHLIVVSNEVGWGVVPPYRLGRIYRDLLGGANQRLAARADRVVLMVAGLPLEVK    
 84 UniRef50_Q9I466        Adenosylcobinamide-phosphat...   185     5e-46  1  34.3%   1:181   1:169     MRDLILGGARSGKSRLAERLAAESgaVSYIATAQAGDGEMGRRIAEHRARRPAHWRTLEEPLALAATLRSEAEAGRCLLVDCLT-------------LWLTNLLLCDDPQRLDGEREALLECLGELPGRIILVSNETGLGVVPLGELSRRYVDEAGWLHQAIAERCERVTFTVAGLPMPLK    
 85 UniRef50_C8XJ17        Adenosylcobinamide-phosphat...   185     5e-46  1  41.6%   3:180   7:180     --TLVTGGVRSGKSRVAENLLADRPAVSYLAPGPvvDPEWADRIDAHRAQRPSHWRTVET----TDLARALGQERAAVLIDCLGTWVTAVVDQLGTWD----RRLAEWQPDFDRQLDDLERAWRSHPGPLVAVTNEVGWGVVPEHRSGRTFRDLLGRVNQRIAAASDDVLLVVAGRTLRL-    
 86 UniRef50_A8F6L3        Cobalbumin biosynthesis pro...   185     6e-46  1  29.8%   1:181   1:168     MITLITGGMKCGKSSFALklSKNYKNRAFLATAVPFDEDMRRKIEKHRIERGNLFETFEEPLNIAGTLKKIDENYEVILFECLTTYLGNLYY---------------YNVDVEKYVSDFVGVISSMKSDIVIVTNEVGWSIVPENNLARKYAETLGKINSKIASFSDRVYVVISGISVRIK    
 87 UniRef50_A8RKD9        Putative uncharacterized pr...   185     7e-46  1  32.0%   1:181   1:192     MITLVTGGSGSGKSEYAEGLILDSprRFYVATMIAYGKEGRDKVERHRVLrgKGFITIEKPRNVGEvlSPLSRTGRALLLECVSNLAANEMFKEGTGKTEAGEHQGGPIQCLSHKIAEDIISLAGQVQDMVIVTNEVDRDGICYEPETMEYIRLMGCLNQKLASAADRVVEVVYGIPVPLK    
 88 UniRef50_C5CE69        Adenosylcobinamide-phosphat...   185     9e-46  1  35.0%   2:181   1:162     -MILITGGERSGKSRLALELakKGEKRAFIATAEAIDEEMSSRIAKHKEERGNLFVTYEEPLDIHEILKKTGD-YDVVVVECMTTWLGNLF---------------HYGRNIDEMVEKFIGSI---NGNEIIVSNEIGMGVIPENPITRTFVEALGRLNARIAQIADEVYFVVTGIGVKIK    
 89 UniRef50_Q47R82        Adenosylcobinamide kinase n...   184     1e-45  1  40.4%   3:180 147:321     --VLVTGGARSGKSSEAELRLLGEPEVLYVATGPaaDAAWAQRVAAHRSRRPAWWRTVET-TDVAAVLAK---ADGAVLFDCVGTWLAHVMGECGMWADEVPAD---AEQRLEERIDALVAAWRTSAAYVVAVTNEVGSGVVPPTVSGGLFRDWLGRVNQRLAAESEEVVLVTAGRVLSL-    
 90 UniRef50_C1SKG4        Adenosyl cobinamide kinase/...   183     2e-45  1  28.9%   2:181   4:166     -ITMITGGAGAGKTAHALTLAAEYGRKLYVATAESTDEEMQVKIDAHKAERDETYQTAEEPLEIHKAVNSAD--ADVVIIDCLTFWVNNLM---------------HYGKDYDEYFEKLMGSLKRSAKPVIIVTNEVGFGIIPWDKETRLYAKLLSKINKQLARSADNVIMMVSGLELRVK    
 91 UniRef50_Q28TZ0        Adenosylcobinamide kinase n...   183     3e-45  1  38.3%   2:181   6:171     -LTLVLGGASSGKSAFAERQVRQCgaKVYIATAEALDGEMAEKIAAHRAQrgQGWRTLEAPHETAKALTE-IEAGEVALLDCVTLWLTNLMVDDGDWD---------------EELEILIDVLLQMRAPVVLVSNDVSGGVMPDNALARAFQRAQGEVNQRLAAHADLVVHVTAGLPVVLK    
 92 UniRef50_Q1Q796        Strongly similar to bifunct...   182     3e-45  1  41.9%   3:181   5:173     --ILVLGGARSGKSSFAETMAKRYKTVVYVATAEIKDDEMRERIRIHRERRPLCWQTIESPYNLEKVVFDQSKKADLVFIDCITLYITNLLVMPA----------NQDSSQIIDKIHTLCRVCEEITSDIIIVSNEVGLGIMPENALARHFCDIAGSANQILAQHATEVYFVISGIAQKIK    
 93 UniRef50_A1TME0        Adenosylcobinamide kinase n...   181     6e-45  1  30.9%   4:181  29:206     ---FILGGQKSGKSRRAEMLARTwhRAVLIATGRAWDDEMRERIARHQRERapGMETVEEPLDVAGTLARCAGPGTLVVVDCLTLWLTQWLMPLPEAPPP---------GDFEPQCRAFLEAVRQAPGPVVVVGNEIGLGVIPLGREVRAFVDALGRLNQRTAEACARVTLMAAGLPLALK    
 94 UniRef50_B5W8I6        Cobalbumin biosynthesis pro...   181     7e-45  1  31.3%   2:180   7:178     -LILVTGPVRSGKSEWAENWAENYArvIYIATSGFDDdeWCDRIQKHRDRRPSDWTTLEVPITLSTTLASVATADNCILVDSLGTWLANLL--------------DWEESQWEQAVTELLQVLLTVTGPVILVAEEVGWGLVPPYPLGRLFRDRLGGLVRLLGTHADSVYLVTGGYALDL-    
 95 UniRef50_B8DJA6        Cobalbumin biosynthesis pro...   181     8e-45  1  37.4%   3:181  24:205     --ILFTGGCRSGKSGLAQRWVESLGprVYIATGAARDAEMAERVRRHQVARGAGWRTVEEQLDVCAALRGCmpRPHGVLLDCITLWLTNRMLAGHDD------------AAILRGVEDLAALLRAATVPVAVVTNEVGWGVVPETPLGRRFRDLSGEANQTLATACTDVILAVSGLPLAVK    
 96 UniRef50_A6BFI8        Putative uncharacterized pr...   181     1e-44  1  33.1%   1:181   1:175     MIHLVTGGSGSGKSEYAENWLTGRNKkiYIATMQPYTEETMKKIehHRLRAGKGFRTLEKYTDLSEL---EIPKNQGILLECISNLVANELYREDGTLNDLKET--------KEKVLAGVRRLSNSTTRLVIVTNEVNADINSYSEETEKYRECIGMVNQSLAELADIVTEVVYGIPVCIR    
 97 UniRef50_C9KJ52        Adenosylcobalamin biosynthe...   181     1e-44  1  45.6%   2:181   4:181     -MILVTGGARSGKSAFAEKLARESgkVAYIATAEVWDAEMEHRIALHRSRRPSDWQTYEAPREAAKVIREAGQEHGTILFDCVTIYLSNLLCRKA-----EPYDEAQLAALVQGAMASLIEAVQGLPEevLFVTNEVGAGIVPENRLARLYRDLAGLANQQLAAAADAVYAVLCGIPLRIK    
 98 UniRef50_B1QY28        Cobinamide kinase n=2 Tax=C...   180     1e-44  1  28.7%   1:181   1:170     MLTLITGGSGSGKSEFAEDLSVssNNLIYIATMFLYDNESLKKVERHKRMRdkNFKTIECFKNLKSLF---ISNNSTVLIDCMSNLVANEMYLEGGAKDKT-----------VQEVIRGIESINNQAENLVIVTNEVFSDGIVYDDDTMRYIRNLGEINKEIGKKADNVVEVVYSIPIFHK    
 99 UniRef50_C4LI10        Cobinamide kinase/cobinamid...   180     2e-44  1  37.0%   1:181   1:200     MKTLVLGGARSGKSEWAEHLVTPPdhVTYVATARPwdADFALRIERHRARRPSWWHT-EDSRDLVDVLTESSDqqTTILVDDLGTWLTHELAEVGMWdeFGSDDWNKGLCAIGARRDRLITALRRVPAdlVVVSPEVGMGIVPSYPSGGVFRDELGRLNADVASVCDRVVLVVAGCALDLR    
100 UniRef50_UPI0001C43096 cobinamide kinase/cobinamid...   180     2e-44  1  32.6%   1:181   1:196     MLIFITGGVRSGKSSYAERRakEKGALYYLATGLADDDEMKQRVEKHQLQrsPHWRVIEQSTNVGERL-PLFKPTDVILIDCLTTLLTNELFN-DWQDEPDKWKDPFYRKKIETKLKSFITHLARGKFTAVLVSNEVSHELF-LDELPLVYAKLLGTLHQHAVCESDEAVLVEAGIPIIKK    
101 UniRef50_C4ZBD6        Probable cobinamide kinase/...   179     3e-44  1  28.7%   1:181   1:208     MITLITGGSGSGKSAYAEKYinGYKEKYYIATMQVFDDEGQRKIDRHRRLrgKGFITIEQPRDIQNAVSKLQSegRSALLECMSNLVANEMFPPVDASGMQAAEAEkqISHVSKKVLKEVSILSENVAELVIVTNNVFEDGVCYDESTMNYIKAMGIVNRGLAAMAERVVEVVAGIPVTVK    
102 UniRef50_A6DZF9        Cobinamide kinase/cobinamid...   179     3e-44  1  36.1%   2:181   9:173     -LSLVLGGAASGKSGFAEALVTGTGrrVYLATAQAFDDEMQAKLVRHRVMRGPDWRTIEAPLDLAPA-LQQAAADDIVLLDCITMWLSNHLLAEHDLEAAQSALLAALDACAA---------------PVVMVSNEVGLSVVPDNALARRFRDAQGRVNQVLAARSELVVHVIAGLPQVLK    
103 UniRef50_B8HV30        Cobalbumin biosynthesis pro...   179     4e-44  1  34.1%   2:180  12:178     -LILVLGPARSGKSEWAEALARRSGrvTYIATsdPDDQEWQQRIHQHRQRRPPDWQTLEVPLALTATLVKAAS-SDCLLVDSLGTWVANGL--------------EQPEADWQQSQQGFLAILAQCHCQVILVAEEVGWGVVPAYPLGRVFRDRLGHLVRHLGGIMDIVYLVSGGYVLNL-    
104 UniRef50_D1B7E2        Adenosylcobinamide-phosphat...   179     5e-44  1  35.8%   3:181   4:175     --ILILGGVRSGKSRLAEVLTSRHRRVLYCATAEALDPEMEERVRLHRERRPPDWETWEG--APEEIFHAVSSFPGAVLVDCLTVWLSRICLADPSFQGDRWQDLKERALEMTRRLFSL-----EGPSHLVVVSNEVGFSLVPPNRMGRRFQELQGMANALGAAACDRVALVVAGVPLWIK    
105 UniRef50_B7GKK8        Adenosyl cobinamide kinase/...   178     5e-44  1  28.2%   1:181   4:178     MIVFISGGVRSGKSSFAEriAEPTDSLHYIATALRTDEEMEARIAHHQAQRkdGWQTWEQPYDL-DCIMPMFGGRDVVLLDCLTNLWANELFRDDIWDVKEK----------VPRIVQQMKQLGNKAKGLVIVSNEIFYDGIPNERGTYTYVHGLGLLHQQIVACSDVAILMRYGLPIVKK    
106 UniRef50_B1XNM7        Cobinamide kinase/cobinamid...   178     8e-44  1  33.0%   3:181   5:171     --ILVTGAVRSGKSEWAEHLALQSQrvTYIATAtpDDPEWMARIQHHRDRRPKNWGFMGESVHLTEAMRR-IPEDHCILVDSLGLWVANHL--------------ETEPAPWYQLTTAFLEAIKSSPRMLILVAEETGWGLVPTYPLGRLFRDRLGRLIREVGLVSDQVYLLVGGHALDIK    
107 UniRef50_Q0SHL5        Bifunctional adenosylcobina...   178     1e-43  1  34.6%   3:181  19:195     --TLVLGGARSGKSAHAEEllAGAGRVRYVATsdPDDHDWEHRIAQHRDRRPASWLTVEtrLDLAGQLRSPTEASAT-LVDDLGTWLTVELDGAAAWDSP--------RGTITPRTDELVASVRDYRGALVLVTPEVGLGVIPETRSGRLFRDEIGALNARLAQVCDRVVLVVAGLTMILK    
108 UniRef50_D2PYX8        Cobalbumin biosynthesis pro...   178     1e-43  1  37.1%   3:180  63:232     --TLVLGGARSGKSTEAERLLASSPDTLYVATGgsADPEWAARIALHRSRRPASWGLAET-IDLVPLLEADGPP---LLIDCLTLWLARTMDACDIWAHP------ERTGEVEQRIEQLAAAWSGTSRVVVAVSNEVGSGLVPADPGSRLFRDLMGRLNTVIAHRADTVLWCVAGRAVPL-    
109 UniRef50_D2B4T1        Adenosyl cobinamide kinase/...   177     2e-43  1  36.5%   3:180 231:400     --TLLLGGTRSGKSAEAELRLAGEPEVLYVATGPsdDDEWTRRVQTHRDRRPAHWGTAET-TDLAGLLRTAEAP---MLIDGLGTWVAAVFDECDAWSGGDGRD------AVTARCDELVAAWRQARAQVVAVSDEVGLGVVPATSSGRMFRDVLGRLNQRLALESEDVALVVAGRLLPL-    
110 UniRef50_A9KMN9        Putative uncharacterized pr...   176     2e-43  1  25.4%   1:181   1:170     MRYLITGGSGSGKSAYAEEIADSFnpVYYLATMQVYGEEGKKRVKRHRLLrgRNFHTIEKSLTVNEV---SIPKDSVVLLECLSNLLANEMFDPIGIGAD----------GVIDGVLRQVELLSEKTTHLIVVSNDIGFDGISYDEGTSLYIKALGELHTRLAVDFEHVDEVVCGIPLNHK    
111 UniRef50_UPI00016C0C9C hypothetical protein Epulo_...   176     2e-43  1  28.7%   1:181   1:165     MFTLILGGAASGKSEYAESLCVHteKKLYVATMQPFGSEAIERIARHHHLRskGFDTLEKYVQLEEFADRS---YHTILVECLSNLVANEFFSYD---------------NFEDNIKRGINSMASQCQNFILVSNKVFSDGYTYEPLTIEYTHELASLNQYFAAKADSVIEVVYGIPVALK    
112 UniRef50_A4BIB6        Cobinamide kinase/cobinamid...   176     3e-43  1  32.2%   2:181   4:167     -LILVTGGVKSGKSRLAADCLTHLTppTLIATARRTDSEMSARIDRHIADRDERWQTIETPLHLADALIRCSQP---VLVDCLGVWLTNLLIET--------------PEQMEEAILQFLQALDQRSAATVLVSNESSLGIIGADALTRRYIDELGLLNQSVARKASHVVMSIVGLPQWLK    
113 UniRef50_C7N887        Adenosyl cobinamide kinase/...   175     6e-43  1  32.6%   1:181   1:173     MFVLVTGAASSGKSAWAEEMAVRAgpRIYIATMQPFGEEGRARVAKHRAQrgKGFSTVECYGDLTSV--ELPPDTESVLLECTGNVAANVLFAQDGSVLDADEAFD--------RIMAGVGHLRSRCASLVVVANEVGSDGVSYSAETDRYVRLLGRVNCALAAQADAVYEVAAGVSQCIK    
114 UniRef50_A8FV96        Cobinamide kinase; cobinami...   175     8e-43  1  30.4%   1:181   1:166     MISLYIGGARSGKSGLAEQEVSDLdpTTYIATATAS-VSMAERIALHREQRPNDWITAEIPLELASSLTELDAKQSVIIVDCLTLWLTNQLMA---------------EHCLIDEIERLCHTLTSLQCHLVLVSTEVGQSLIPDDEMSQQFVTSSGLMHQKIAAIADRVNFCQGGLTTRLK    
115 UniRef50_A5TYY0        Cobinamide kinase/cobinamid...   175     8e-43  1  37.2%   1:180   1:174     MRILVTGGVRSGKSTHAEALLGDAADVVYVAPGRPadPDWDARVALHRARRPPTWLTVET----ADVATALSEARSPVLVDCLGTWLTAIMDGEALWSAATADVYAVLE----ARLDGLCAALTGLP-TAIVVTNEVGLGVVPSHSSGVLFRDLLGTINRRVAAVCDEVHLVIAGRVLKL-    
116 UniRef50_B0PB91        Putative uncharacterized pr...   174     1e-42  1  33.7%   1:181   1:170     MLTLVTGGAASGKSEYAERLAAadGPRVYIATMRPLDKESVARIEKHRAArdRRFSTIERYHDLKGL--RLPCGTNAVLLECMSNLAANELFGEGSAG-----------KAAVSAILDGVDALCAQARDVVIVSNELFSDGEAYAPETLCYLDVLGEINRTVAQRAHRVIEVVCGIPVIHK    
117 UniRef50_D1PMC2        Cobinamide kinase n=1 Tax=S...   174     1e-42  1  27.6%   1:181   1:174     MLVLVIGGSGSGKSEYAERllADDMPRYYLATMQVWDEECRKRVEKHRHQrgRGFVTVERTRDLAGISPAMLDNGGTILLEDLGNLAANELYAPG-----------QSFRQAEEKILKGIENLHAVCRHLVVVSNEVGTGGADYAGETEIYLRLLGHLHQEIAKRADAVCELNAGLPIFYK    
118 UniRef50_C1A5N1        Bifunctional adenosylcobala...   174     2e-42  1  38.2%   4:181   8:187     ---LLLGGVRAGKSGRAVALaqSDAALFFVATAQAFDDEMQQRIANHQAERSARWRTIEAPVSIVPAIDEALSarRVVVIDCLTLWVSNLLLARADDELRD------AEPYVAREVAALVTCMQhaDVQWVVVSNEVGLGIVPHTLLGRAYRDALGRANQLVAAAAGTVELMVAGIVLPLK    
119 UniRef50_Q2JSJ7        Putatitve bifunctional aden...   173     2e-42  1  31.8%   2:180   3:171     -IVLICGPARCGKSRLAESLAAASgpVVYLATGPkaDPEWAERVQQHRQRRPPTWQTWETGPDLGADLQKLSQP-CCALVDSLGGWVA--------------QGLECSPEEWDPLVDAFLSALQSWAGKAILVSEEVGWGVVPAYPLGRRFRDRMGELTQKLAPLADQVFLVAAGFVLDL-    
120 UniRef50_B2J7V6        Cobalbumin biosynthesis enz...   173     2e-42  1  35.2%   2:180   4:170     -IILVTGPARSGKSEWAETLAMESGkvVYVATAttDDQEWHQRILEHQQRRPQDWVTLSVPIELSATL-ADAKPYTCLLVDSLGTWVANLL--------------EEDESSWENIVVELLETVELVAADVLFVAEEVGWGVVPAYPLGRMFRDRLGSLVRQLAALSETVYLVTGGHVLNL-    
121 UniRef50_C4Z7P7        Adenosylcobinamide kinase /...   173     3e-42  1  27.1%   1:181   1:171     MLIIITGVSGSGKSEYAEQilAGDNKKYYVATMQPFGEEGRIRIEKHKRQrgKGFETIEQYQNIGSALDCCdeERPVVLVECMSNLLANECFGEAGKPDD---------------IFDGCMKLYSGCRHLVIVTNEVFSDGCEYDAGTTDYIRRLGEINVRLSRAADAVVEVVYSIPVFLK    
122 UniRef50_B7ATE1        Putative uncharacterized pr...   172     4e-42  1  27.2%   2:181   4:194     -LILVSGAGASGKSEYAEKLAvhEDRLIYVATMSAYDDESRKKIEIHKKRrnTDFETIEKPYGIEEIIPFITpkKSTILIECISNLLANEMYGRAETGVkdSGMSQLQLQPSQRIIDGITAIADTQLADIVVVTNEVFADGMEYDASTMEYIRQLGRINCELATMSDMVVEVACGRPVVWK    
123 UniRef50_C8NQ52        Cobinamide kinase/cobinamid...   171     9e-42  1  33.0%   6:181   2:170     -----LGGARSGKSVFAEEIA-GPGPVVYVATARPwdEDFAARIAAHVARRPAGWTT-EDRRDVVTLLREPTSA--TMLVDDLGTWLTHVTDTCGTPAW------EHDHPGLTAEMDALVDAVATYSgnLVIVTPEVGMAVIPEHRSGRLFRDRIGTLNQRLATVCERVVLVVAGLPLELK    
124 UniRef50_Q7NML8        Bifunctional cobalamin bios...   171     1e-41  1  31.1%   2:181   5:177     -LILVSGPARSGKSQLAERLAVSSARVTYVATGwpDDADWQGRLARHRKRRPACWSLVETGAPGGPALEaeAEADECLLIDSLGGWLGARLLA------------DLAEESLAQEVAALPGQLHRCAARVIAVSEEVGWGVIPVYPLGRRFRDLLGELNRNVAREADAAYLVANGYALDLK    
125 UniRef50_A2SI75        Adenosylcobinamide kinase n...   170     2e-41  1  33.1%   4:181  16:193     ---LILGGQRSGKSRCAESRAADwrSAVLLATALAGDDEMRSRIARHraERVPGLATDEVPRELAAAVRRHSEPDRMVLVDCLSLWLTNLRMPMQGAAVTDAE--------LDRHVADLCEALRSARGPVVLVSNEIGLGLAPLGAEARRFVDDLGRLHQAVAAQCARVTLMVAGIELPVR    
126 UniRef50_A8LFC4        Cobalbumin biosynthesis pro...   168     7e-41  1  35.8%   3:181 308:469     --VLITGGTRSGKSAQAEDWLRAEPEVVYVATGWasDPEWAARVAVHRERRPARWHTVET-QELESLLR---SPGPALLVDSVSLWVAARLDDPD----------------FGAAVDRLVEAWRATRRRVVAVTDEVGSGAVAPTAAGRLFADRLGQVNARLAAESDEVWLAVAGLATRLR    
127 UniRef50_UPI0001C352E8 putative cobinamide kinase/...   168     7e-41  1  34.8%   1:181   1:216     MVTLVTGGSGSGKSAFAEQEIVKLgrRIYIATMKPWDEECRRRIERHRVMrdKQFETIECYRGLDraAGKEGEAGNAVLLECLSNLVSNELFGTGDDDCPDRLSSQYGSATADLVVGGIMRLMRQAD-DLVIVTNEVFsgKCPedESTALYLKVLGEVNCRLGAAADRVTEVTAGIPVIIK    
128 UniRef50_Q9KCI1        Cobinamide kinase/cobinamid...   168     1e-40  1  29.3%   1:181   1:186     MFVFISGAVRSGKSSYAEARAIEsgQLYYVATSTVADHEMASRIKHHQQQrgVPWNVIEAQVDIGS-LAANFDERDIVLIDCLTTLLNNELFRT---LDAKEYSLAKEKERTVAKLSQELDLFLHGNWTTLLVSNEVGDDMPYEDEYTLAYQHALSLLHQKLVREGDEAVLVEHGIPLVKK    
129 UniRef50_A8SFV4        Putative uncharacterized pr...   167     1e-40  1  33.1%   1:181   1:169     MLTLVLGGAASGKSEYAEALVLRSapRYYLATMQVWDAECAARVEKHRKMRAaqFETLECPLHLETV---HLPRRGTALLEDLGNLTANELYDPAGAGDAA-----------AEHILQGLESLAAQCENLIVVSNEVFSGGADYAGDTDRYLLALARVNNALAARADAVVRVVCGIPVYYK    
130 UniRef50_UPI0001909A2A adenosylcobinamide kinase/a...   167     1e-40  1  38.3%   3:151   9:143     --TFILGGARSGKSRFAENLVVSTgdRHYLATGRAWDDEMQARIAQHRADRGPSWTTHEEPLDLVGKLAAIDGEGRIVLIDCLTLWVTNLMME---------------ERDMTAEFTALADFLPDAKARLVFVSNEVGLGIVPDNRMARDF------------------------------    
131 UniRef50_UPI0001AF4286 bifunctional cobalamin bios...   167     1e-40  1  34.8%   1:181   1:178     MRTLVLGGIRSGKSRWAEHAIADsrPVRYLAPTPVTeqEWAQRVAKHRERRPGHWSTVETD-DIITQLRR--SPDTATLVDDLGAWLTGTLDRHRAWDN----------GSVAGPVQGLLDAVRAFESTLVLVSPEVGLTIVPATASGRRFADELGSLNQQMAAVCDQVVLVVAGQAVPIK    
132 UniRef50_B0G7Q1        Putative uncharacterized pr...   167     2e-40  1  29.3%   1:181   2:208     MMHVITGGSGSGKSAYAEMWLTGKPEklYIATMRPFGAETQKKIERHRQMrgKGFQTLECYGDldDSIQreNAKTGGILLECVSNLLADVLYQEDGSLAED--------EVVLEMIVEGIRYLNTQTERLAIVTNEVHSDLQDYSEETKKYIGLLGKINQELGKMADQVTEVVYGIPIKIK    
133 UniRef50_B6IQN5        Bifunctional adenosylcobala...   166     3e-40  1  30.0%   2:181   4:172     -VTFLTGPVRSGKSARAVEIARGWgnVVFAATYrpADAEMLARVRRHQEERPEGWRTLEAPDDLTAALDALDPPPSGLILDSIVIWAAMRFDRDD--------------STILTEWSAVLEHLRAAPWPTVIVGDEIGWSPVPMEAELRRFRDLVGWLGQRTAAAADEAWLMVAGCPVRLK    
134 UniRef50_A5KJD6        Putative uncharacterized pr...   166     4e-40  1  31.5%   1:181   1:185     MMELVTGGSGSGKSAYAEDRikKEQKLYYIATMYPYGTETEEKIADHRRRrgKGFRTLEWYTNITEKieASGEALGCVLLECVSNLAANELYMEEGAKDEA-----------VRVVAQAMAMLKKKSCHLVVVTNEIFSESAKDSEEMRKYKYIMGEINKELAKMADEVTEVVCGRPLRRK    
135 UniRef50_UPI0001C36F2A putative cobinamide kinase/...   165     8e-40  1  25.4%   1:181   1:168     MTTLITGGSKCGKSTFAEKLLshSGRKIYIATLRPYGNNAEDIIARHIKMrgKGFVTIEQFTDINKAPVKDS---DAVLLEDIGNLAANEMFTENGIVSP------------VTKVVSGIKTLSEIVSELIIVTNEVGCDGIGYAPATMDYIAAVSSINRSIAEFADNVYECVYGIPVTLK    
136 UniRef50_A9DVL9        Bifunctional adenosylcobala...   164     1e-39  1  34.0%  26:181   2:141     -------------------------PKTYLATGRIWDDEVQERVNKHQARRDAGWRTVECPLDLSEPLAKL-PAGEIVLIDCATMWLSNHLMEG---------------SDLAEAQAALLDALRGCAAQWIIVSNEVGQGIVPDNAMARQFREAQGRLNIALAAEAETVVQVVVGLPQLLK    
137 UniRef50_A0QF00        Cobinamide kinase / cobinam...   163     2e-39  1  33.7%   1:181   1:174     MRTLVLGGIRSGKSQWAEEAVADgrRVRYLAPGPPgdAAWAHRVAEHRDRRPAHWSTIETD-DIATELRRC--PQVPTLVDDLGGWLTGMLDRHDGWQG----------GSVTAPVDDLLAAVAEFAAALVLVSPEVGLTVVPATASARRFADELGSLNQRLARLCDRVVLVVAGQPVPIK    
138 UniRef50_B1HXM3        Cobinamide kinase/cobinamid...   162     4e-39  1  26.7%   2:181   3:191     -LVFITGGVRSGKSHFAEQAasTEKRLMYIASGIALDDEMKKRIDRHQADrpMQWITVEAPYNIAPVFETLKD-GDVVLWDCVTTWLTNAFYEGYESGAPCLTKPGCLASKLHT-VKQAILSLLTKNVTLLVVSNELFDEPPYQSEEVELYRRTLGQFHQWFVVMAQEAFEMNYGILKRWK    
139 UniRef50_Q746N0        Cobyric acid synthase/cobin...   162     6e-39  1  35.5%   9:180 490:642     --------AKSGKSRFAQRLAGPFA--TLIATAEARDEEMAERIRRHQEERPPTWETLEEPLDLPGALKRARHP--TVVVDCLTLWVANLMERGLDPLL---------------EARRFLSAVEESGKRVIAVSNEVGMGIVPQNPLARRYRDLLGQVNALLAEAAQEAYLLVAGRALPL-    
140 UniRef50_Q30UD8        Adenosylcobinamide kinase n...   161     8e-39  1  29.1%   3:181   4:165     --TLFIGGIKSGKSLNAQnlASSLQKPIYLATTEFIDKELQERINAHKQSRMDSFETIEEPLKLYNKILEC---KSAILVECVSMWINNMLYHGFTFADMKEE----------------LEKILELDKTVVFVLNDIGSGVIPDNALAREFVDISGKLSQLIASKCDEVYHTIAGISTRIK    
141 UniRef50_UPI000185C578 cobinamide kinase / cobinam...   161     8e-39  1  35.4%   1:181   1:194     MRTLVLGGARSGKSSWAEHeaAASTVLHYIATARPwdSDFHSRVEEHRIRrgVAWHTV----DDVDAVDALASPKRRMLLDDVGTWLTYIIDAQGMWEAP--------RGSVAPWTHSLVDAVRNFPAdlFIVSPEVGFGVIPEHRSGRLFRDEIGLLNQQLAAVCDRVVLVVAGCPMEVK    
142 UniRef50_A6CHV3        Bifunctional cobalamin bios...   160     2e-38  1  27.2%   2:181   5:180     -VIFVCGGVRSGKSSFAESKAarSGTLHYIACGKAIDEEMKQRIDRHQQDRkaGWTTWEQATSLGE-IAENFSDKDIILVDCITTWMTNEIYLENIPA-----------EDVTPNVMRDINKVAAKAGTLFLVSNDVFCEPLSENEWVKRFTSILGTLHQEIVSMADTAYSVKHGVAIVKK    
143 UniRef50_C9S017        Cobalbumin biosynthesis pro...   160     2e-38  1  32.0%   1:181   1:179     MMVFISGAARSGKSEAAEACasRGGRLHYIATAQAMDEEMEARIRRHQERRAahWTVWEAPFS-SQEIAASLRPDDVVLLDCLTAWLAYELFSGE------HWKTEEDDRATARRLLDGVRAWDAACRAVVIVSNELFAGGVPDDPGTFRYMKTLGSLHQQLVAEAAAAAVVECGL-LRVK    
144 UniRef50_A4E6L4        Putative uncharacterized pr...   160     3e-38  1  29.4%   2:181   3:176     -VTFVIGAAASGKSAYAESllGHDGPRVYLATMEPFGEEGARRIARHRALrgKGFSTLERTRDVGAAV-PGLPRGCTLLLEDVGNLVANELFAEGGLSPRDP-------DAVAREVLGGIERLAQAAAYTVVVSVDVFADGMRYDEGTEAWRRALARVNAGVAALADRAVEVVCGIPVWMK    
145 UniRef50_C6C0R8        Cobalbumin biosynthesis pro...   159     4e-38  1  27.1%   1:181   1:167     MITFVLGGNKSGKSDYALDLFAesGRKCFIATGKARDMAFRQQIMDHRLERDPSIPVLEAGADLRQVLLKAREGYDHLLVDSLDFWL------------FSCSEVADGEQQI-GEVVRLLSEWKG--PDVVLVSCEVGLGPVAMTREVRSFVRRLGSLNRTMAAIADEVYLVAAGLPLTLK    
146 UniRef50_B6WXR8        Putative uncharacterized pr...   159     5e-38  1  38.5%   2:180   6:189     -LTLFLGGTRSGKSALAEAlaRAQGPVWYLATARpdDPAMAERIRRHRSRRPAHWHTLECPRhlAPLLAAQAppMPTVLLDCVTLWMSNILFALD-----DPQDAAAFEASLREEVEGLLHTMRAFPCRWVLVSGETGLGGIQAERLARIFDDGLGLANQMLAAQARDAFLVVAGRCLRL-    
147 UniRef50_Q2J8A6        Adenosylcobinamide kinase n...   158     5e-38  1  35.8%   3:181 338:500     --VLITGGARSGKSAEAERRLLAEPEVVYVATsdPADAEWSERIAAHRRRRPAAWTTVET-VDLVPLLR---SPGPPLLIDGLGLWVGAWLDRPD---------------ELRIRAEELVDAWRATGRRVVAVTDEVGSGVVPPAEAGRRFRDVLGRLNADLAAEADEVWQVVAGIPLRLR    
148 UniRef50_C6LEQ0        Putative adenosylcobalamin ...   158     7e-38  1  30.9%   1:181   6:176     MFMVVTGGSGSGKSAWAEqlKLGEQKRYYIATMQCADEESRRRIERHRRmaGKHFQTLECPADLERLF---LEPGSTALLECMSNLTANEFFDG----------KKHTPQETAAKIMTGVEKLKGQCANLIVVTNEVFSDGAVFDEWTTQYLECLGSINCAMARMADCVAEVVYGIPVILK    
149 UniRef50_C0BZ87        Putative uncharacterized pr...   158     1e-37  1  27.1%   1:181   1:188     MLYLVTGGSGSGKSAFAEDLiqKPGRLFYIAAMMPFGAETRQKIRRHRtrRDKGFETVECYTAIETPAKEGGpaDAYVLLECMSNLTANEMYAPEGAGPDT-----------VDAVLRGIEILYSRCRVLVVVTNDVFGEGEAGTGGMKEYRETLGEINRRLAKMAGQVTEVVCGIPAAVK    
150 UniRef50_C7MXA5        Adenosylcobinamide kinase n...   158     1e-37  1  38.8%   3:180  37:208     --TLVLGGVRSGKSRHAEELMSGYRYVTYVAGSApdDPEWAARVAAHRARRPAHWRTIET-LDIAGTLRQVTSP---VLIDCLGTWLARVLGEVGAWEQRPGW-----QRAVDERLQDFVDAWQTTTVPVVAVSNEVGSGVVPATHSGRVFRDVLGALNTAVAAGADSVRLVVAGRVVHL-    
151 UniRef50_UPI0001743FC9 adenosylcobinamide kinase/a...   156     2e-37  1  32.0%  30:179   1:159     -----------------------------MATSLVFDEEMKEKVRLHKKRRKDEWFTVEAYKNFENELSNFFENNDKilVDCLTNMITNIIFENQNIDWDNFEklEKLNKDVEHSVIKLLN-VADQFENAIIVSNELGMGLVPSYPLGRYFREIAGKMNQIVAETADEVYLVVSGIPMK--    
152 UniRef50_Q8XLK6        Probable cobinamide kinase/...   156     4e-37  1  25.4%   1:181   1:175     MIVLIIGGAKSSKSSYAEFYSsgKGELYYLATMKPYDSEDLKRIENHLKNREkdFKTIEKHRNLNEIFHKLSKE-DTVLLDSLTSLVTNEMF-----------VGKEFNESVHSNILKDIKSLGTKVSNLVIVSDYVFSDGIKYDSYTESFKRELGKINCELASFSDVVIEASFGNLIFHK    
153 UniRef50_D2LHR1        Cobalbumin biosynthesis pro...   155     6e-37  1  33.3%   2:181   4:178     -IIFLTGPVRSGKSRRAVDIAESYgrVAFVATydPADAEMAERVRRHQDERPATWRTLEAPDDIVAALAALDPAPSCVLIDSLVTWLAFRTGFGGREGMTDD--------AILAAWSRELDGFRAAPWPTVIIGDEVGWSLVPMDADLRRFRDLAGFLGQRTAAAASEAWLMVAGCGVRLK    
154 UniRef50_C7QD52        Cobalbumin biosynthesis pro...   153     2e-36  1  39.9%   4:181   1:181     ---MILGGARSGKSSEAERraGTAHAALYVATgrDGDADWAERVRRHRERRPDSWTTAET-TDVAAVLRAATQP---VLVDCLTLWLTAMMDDVGAWDDQTWHDTGERE--LAARFDELEAAWRAATVPVLAVSNEVGLGIVPESAGVRRFRDEQGRLNQRMAAASEGVVLMVAGIAVVVK    
155 UniRef50_Q0IAI8        Adenosyl cobinamide kinase/...   153     2e-36  1  29.6%   2:180  14:179     -IIVVSGPSRGGKSRWAEHLLNAQESVTYVATsrSNDPSWEERMRLHRERRPLHWQLREPGSKLAECIRRE-EANQPLLIDALGGFTALHLDHNDL--------------QWEEEVEELIQSLLTRKRPVVIVVEETGWGVVPATKIGGLFRDRQGWLAQRLEQHATDSWLVVQGRALNL-    
156 UniRef50_C6I043        Cobalbumin biosynthesis enz...   153     2e-36  1  32.8%   2:181   4:173     -LVLVTGGIRSGKTAFAMSLLVhgNDWLYWATGKALDAEMEERIARHRKERPEGVMTLeeGIDSGNLAGEETWARMPVLLDSLGFCVLETL----------------SEADITVWMDRLSELVAGRPGPVVVVSEEVGWGGISMDRSARLFADRLGLWNQRLAREAGSVYAVMAGCPLRIR    
157 UniRef50_D1A8Z3        Cobalbumin biosynthesis pro...   153     3e-36  1  36.3%   3:181 151:318     --TLVLGGVRSGKSAEAELRLAACPQVTYVATAApgDAEWAARIEAHRRRRPHWWRTVET-TDLAGVLR---SATGAVLVDGIGSWLAAVMDETGAWDDP---------SRLEPRLEELVAAWRATRARVVAVSDEVGLAPVPLTAAGRAFGDRLGRLNQRLAAESEEAVLVVAGRVLELR    
158 UniRef50_Q2B552        Bifunctional cobalamin bios...   151     9e-36  1  31.1%   2:181   7:188     -LIFITGGVRSGKSTFAEKTaaSNGRLHYIAAGKSSDEEMAERILLHQKQrgSGWRTWEQPAGIGE-LSAAFTKRDVLLLDCLTTLLNNELFGTGGR-----WESPEFQEAVKERILTDIHSLKESAAALIIVSNEVKYEPIETGSVSHIYARLLGRLHQRIVGMAVQAYLVEAGIPLLMK    
159 UniRef50_D1Y5I0        Adenosylcobinamide kinase n...   151     1e-35  1  26.4%   4:181   1:165     ---MVIGGWRSGASAFALKLAQDWERKTIVSTQTSTEADVLEHIALYQKGLDDGCETIVEGFDLARALDKVR--GGVCIVDDLGAWVSNLTNGSSRFAGETC-----------PEIEAFVGKLRLPPCEVIVVTRELGMGLSSERIAERRYRDVVGRLNQRVAALAASVYLCVSGLPLKLK    
160 UniRef50_Q30VK8        Adenosylcobinamide kinase n...   150     2e-35  1  26.0%   1:181   1:167     MIRLILGGDKSGKSAFALSALQEggPHLLLATGQAADFSFRRQILEHRTARAPHIPVRETGTDLVSALLRGRDGFGSVLVDSLDFWL-----------------FACREAGMQQYSGDLAECLrgRDTEITLVSCEAGLGPVPADRATRMFIRELGALNQTVAALADEVCFMVAGIPMYLK    
161 UniRef50_C1I2L0        Putative uncharacterized pr...   150     2e-35  1  26.2%   1:172   1:165     MIILVVGGSKSGKsrLAKKLESKDSNLYYIATMKPYDKEDIKRINNHLIERDggFKTIEQGRNIEEVAAKV-KKGDTLLLDSVTSIVTNEMFIE-----------EQFIMNVSEKIFDGIKKLSSKDINLVIVTDYLFSDSIVYDDYTEAFRREIGKININLAKISDIVIEC---------    
162 UniRef50_A5GKT3        Bifunctional adenosylcobala...   150     3e-35  1  30.7%   2:180  10:175     -LVLVSGPSRGGKSRWAEHLVSVCSEVTYIATSppGDAAWQERLRLHRDRRPANWSLLECEGQLTAALQK-APQTHGLLIDALGGFTAAHL--------------QTDAQEWDALQIELLTSLKQRQEPVVIVIEETGWGVVPSTAIGGLFRDRQGALAQRLASHANRSWLVVQGRALDL-    
163 UniRef50_A8LYD9        Cobalbumin biosynthesis pro...   150     3e-35  1  39.1%   3:181   9:180     --VLVLGGIRSGKSEFAEFLVADAPMVRYVATAADidEEWAARLEAHRARRPETWTTEEtpRRLATVIAA-AQPSETLLVDDLGGWVTALLDPAHRPADDT------------ATITELAEAVRSCPARLVVVSSEVGLSLVPTTPLGRAFADALGTANRAIADAADAVALVVAGQPSWLK    
164 UniRef50_D1SDN5        Cobalbumin biosynthesis pro...   150     3e-35  1  37.6%   4:181  10:180     ---LVLGGIRSGKSEFAESVVADAPTVRYVATAPAGDPewATRLAAHRARRPGSWSTEEtpGRLVEVIVAAG-PNETLLVDDLGGWVTVLLDPAHQPADDT------------ATIAELAAAVRSSTARLVLVSPEVGLSLVPTTPLGRAFTDALGATNRAVADACDAVALVVAGQTAWLK    
165 UniRef50_UPI00019023F1 bifunctional cobalamin bios...   147     1e-34  1  31.2%   5:180 157:327     ----VTGRASAREsrTPKRLLGDAADVVYVAPGRPadPDWDARVALHRARRPPTWLTVET----ADVATALSEARSPVLVDCLGTWLTAIMDGEALWSAATADVYAVLE----ARLDGLCAALTGLP-TAIVVTNEVGLGVVPSHSSGVLFRDLLGTINRRVAAVCDEVHLVIAGRVLKL-    
166 UniRef50_Q46KZ1        Adenosylcobinamide kinase n...   147     1e-34  1  26.8%   2:180  12:177     -LISITGPTRSGKSQLAEFLIKKQQSVTYIATsrPNDPDWQQRIDLHKKRRPDRWKLIEHPKDICKAIES-ISKNGSILIDSIGGLVEHHLGDDDTQWEIFQ--------------DKLLNCFTDDNLLIVFVSEEVGWGIVPATPIGHLFRERHSTLTSLLSCRSKKRLLAINGIAIDL-    
167 UniRef50_A3EUZ9        Putative cobalbumin biosynt...   146     4e-34  1  28.9%   2:181   3:179     -LRLVIGGIRSGKSRFAEEMALRDgpWIYLPTAFPSDQEIKARIEKHRQERDERWDLF--------PLSDIPEATDAFL-ERVMGVPSGATLLLDGLGLFLGQVFLGQepKTLENVIPFCDWLSSRKGLTIVVSDEVGFGGVPLTPAGRHFADALGETNQRLAEKAISVYLMVAGFPLTVK    
168 UniRef50_A9GM42        Adenosylcobinamide-phosphat...   145     6e-34  1  37.1%   4:181  13:182     ---LIGGGVRSGKSAFALSLARsgERRAFIATAEPFDDEMRARIDAHVLERGGAFLTVEEPIALPERI-ASLSGVDVVVVDCL--------TLWLSNLLLRDETEGRALGPIEERIEALAAAVESAAPHVVLVSNEVGMGVVPESRLGRAFRDLAGRAHQRLGRSASELYVAVMGAILRLR    
169 UniRef50_A8EWS3        Bifunctional cobinamide kin...   145     6e-34  1  25.4%   1:181   1:164     MKIFYFGGQKSGKTKAGIKKasTTKKPYYIAtnSFGDSSMSERINKHIIERKNDFITIEEPKDLTKVIK----ENNTYLIDCISMWLFNNL--------------QNNEESLKLQLSEIC----KIEANIIFILNDVSCGVIPFDKESRRFVDYSGIIGQELVKLCDEVYEVKYGIERKIK    
170 UniRef50_A7B6V5        Putative uncharacterized pr...   145     6e-34  1  25.8%  23:181  14:169     ----------------------NSRHLYYIATMVPYGKETEQKILRHRQMrgKGFETLECFTDLKKMVQTeaEEGICVLLECMSNLTANELYLDTGAK-----------ERTREAVLEGIRELEKRCRGLVAVTNEVFCDLPPADEEMQEYLSVLGTINCRMAKMADQVTEVVYGIPVEVK    
171 UniRef50_Q7VBW8        Adenosyl cobinamide kinase/...   144     1e-33  1  27.4%   2:180  10:174     -LILVSGPIKSGKSRWAEKLIFKEKNVTYIATHEVIYddWIERIRLHKQRRPSHWQLIETS-DISSSLKS-IDKGNSILIDSLGGVVSKYL--------------NYDSVKWNTYSSLIIEKLTKFEGVIVIVAEEIGWGVSPYTESGNIFRDRLSELTEKLDTYAKQSWLVIHGRAINI-    
172 UniRef50_UPI0001972E8B adenosyl cobinamide kinase/...   144     1e-33  1  27.6%   1:181   1:172     MLAVVTGGSGSGKSEYAEGLaaEPGRKLYLATMMVWDEEGRERVRRHRRMrgKQFRTEEVFSDLEQFELPDGWEKgtILLECMSNLVCNEFYR--------------QEEGAFVRITRGLEHLLDLSRNLIVVTNEICSDGRFYGEETERYRRLLGEVNCFLAGQAQTVTEVVYGLPILWK    
173 UniRef50_D2L2C4        Cobalbumin biosynthesis pro...   143     2e-33  1  25.4%   1:181   1:170     MIRLLLGGTRSGKSALGEAlaAGSPPRRVVATGRALDFAFRERIAAHKRARPAGVAVIEAGAAAMDVLGREAGHGGTILFDSLDFWL------------FACHDLGKTQSSLAALARGLAPYQGADGPELIVVSAEIGLGPLAADASVRRFADALGTLNQAAAAMAGDVRLVVAGLSVALK    
174 UniRef50_B2UXE1        Putative uncharacterized pr...   143     2e-33  1  23.3%   1:172   1:163     MNCLIIGGSKSGKSNIGEKIALskDKVIYIATMSPYDDEDKKRVEQHIINrgLNFITLEQFRDLNETV-KYIHKEDTILIDSITSLLINEMF-------IKNDIIKYPSLKIINDIKEIINTVK----NVVIVSDYIFSDSIEYDEISENYKRELGKINKELADICDTVMEC---------    
175 UniRef50_C7LWY8        Cobalbumin biosynthesis pro...   142     5e-33  1  24.3%   1:181   1:168     MIDLVLGGNKSGKSDFgeLLCRGPRPWTLVATGKSRDLAFRRQITTHRQNRDADIAVREVDTDLAGALGALAPSGGSVLVDSLDFW----MFSLAGSRDDG--------KRMREEFFAGLRDWRG--GNLILVSTEMGLGPLAFDGEIRAFARDLGQLNREIASVSTSVYLVVAGLAQKLK    
176 UniRef50_A9BAH0        Putative cobinamide kinase ...   141     1e-32  1  29.1%   2:180   9:174     -LTLVSGPVKSGKSKWAEQILQDYSNVTYVAtsDKEDINWLDRISKHKQRRPSSWKLIENIIDLNS-LFAGISSNEPILIDSLGGIILKYLNYNDYEWTAIE--------------SQFLRLVQTFTNHIVLVIEEVGWGISPPTIEANLFRDRLGELVHKLEYIAHDSWLVLHGRAINL-    
177 UniRef50_A1UIA2        Adenosylcobinamide kinase n...   140     2e-32  1  33.7%   1:181   1:173     MRTLVLGGIRSGKSRWAEAVIaqPDPVRYVATgpGADDEWARRVAAHRRRRPSGWRTTET-TDVPGALR--DDPATATLVDDIGGWLTAEMDRCDAWHGGSVAAGADALVAAVAEF----------TASLVLVSPEVGLTVVPATAAGRRFADELGALNQRLAATCERVVLIVAGQPITVK    
178 UniRef50_Q31AU7        Adenosylcobinamide kinase n...   137     1e-31  1  22.3%   2:180  15:177     -IIFITGGTKSGKSEFAEHLAKEVKKLSYVALSeiDDKEWQEKINIHRNRRPKYWKLIET----TDLLNTLSKEDGPLLIDSIGGFV--------------MENIGKEHNEWSTKMYSLINLLIKRKSITFIVGEQVGWSLVSEYKIGNTYIERIGELQKRITKISKDNWLAINGRAIKI-    
179 UniRef50_C4GBH6        Putative uncharacterized pr...   136     4e-31  1  24.3%   1:181   1:204     MMHLILGGSASGKSEYAEkrLAANQPLLYLATMKGDDPETlrIDRHVRRRRGMGFVSLEIPYNLdaLHLQTFSAKGVILLDCVSNLLANQIFDRHAMAYDPD------------RFCEGILSLREICKDLLIVSNNVHEDGICYDEVTQDYIAQLGLINRRLGRASDRVTEVLAGLPVLLK    
180 UniRef50_C4XNU2        Adenosylcobinamide kinase/a...   135     8e-31  1  26.5%   1:181   1:168     MIQLVLGGVRSGKSALGEELLAQGppRRVVVTGKALDVAFRERILAHKRARDPQLAVIETGAEAMDVLARESAHGGTVLLDSLDFW----LFACHGDDADRRVRLA----------RGLAPYAAPDGPRLVVVSSETGLGPIAADPATRRFVDALGALNQAVAAAAHDVRLVAAGLSIQLK    
181 UniRef50_A5GTC8        Bifunctional adenosylcobala...   133     2e-30  1  29.4%   4:180   8:178     ---LITGPSRGGKSEWAEQRIReaAAITYLATGppDDAAWQQRLSRHRQRRPEHWRLLEASsaVSQLLQQGSdqEDFVLLDSLGGLVA--------------SALELEEECWLELQAAFLMALEKRSTPVVLVAEEVGWGVVPPTAIGGRFRDRNGSLTRQCEQLCSESWLVAAGRALPL-    
182 UniRef50_D1Y8A0        Adenosylcobinamide kinase n...   132     5e-30  1  27.6%   1:181   1:166     MLILLIGTSNSGKSRFAEKIASRfgPRIYAATMVPCGAAGAARVDKHRRQrgRGFVTVECPRGLDGI---SAGKNALVLLEDVSNLLANEMFGRHDPRAED-------------EALRQIVSLAGRVAVVIAVT----IGGVSGdePTQNYAAALAHLNEQLAEAADAVIEIRAGTPLLLK    
183 UniRef50_C6LEQ2        Cobalamin biosynthesis prot...   119     3e-26  1  19.4%   2:181   1:155     -MKLIIGGSYQGKKEAA-------GRLFGLCASDFTDG---------RTCAYDEIFTCRAIADFHEFIRRFMQEPEQM---DASG------VNAEPRQPENPEVDAEPDAPAYSRLNRLPQELAEKNPQICIVSNEIGYGVVPVDAQERAWRELTGRICCRIAADSDTVVRVAAGIPVVIK    
184 UniRef50_UPI0001850D59 cobinamide kinase/cobinamid...   114     1e-24  1  21.1%  40:181   1:132     ---------------------------------------MFERINRHQKDRNNswVTIEKERDLDEIFH-LLKPQDVIVIDCLTTWLSNEMFSVSTVLNPKN------------KMIQTIKSILKKSAIVIIVSNEISFEWIEPNSLTYSYCETLGELHTWIVLTCSKAIEMDMGIPIIHK    
185 UniRef50_C5EU42        Putative uncharacterized pr...   111     2e-23  1  20.0%   2:181   1:145     -MILVIGGRSQGKREFVQQNLIPEADAGTVRWASGGDGGWE------------SYMNSRYCCDFHLFIRR---------------LMSHELGVGANGDPWKPGD--------EKQMEEILKALREDAPDRILVTDEIGYGIVPADAMERQYREETGRLCCLAAKEADEVWRVLCGLGQRIK    
186 UniRef50_B0G7P9        Putative uncharacterized pr...   109     3e-23  1  21.1%   2:181   1:124     -MIMIIGGAYQGKLAYAKETFPDV---------RWTDGEQCEKEAIFQYR---------GIFHFHKYIERLLSEG--------------------------------------EDISELAKQLKEKNPDLILVTDEIGYGIVPMDPFLREVRETTGRICTELAKDAKSVIRVVCGIPTVIK    
187 UniRef50_C0B8A4        Putative uncharacterized pr...   106     5e-22  1  22.8%   2:181   1:128     -MKMIIGGAYQGKLAYAKKQNP------YI---HWTDGELCE---------GDNIFEAEGVFHFEKYIQSMIKK----------------------------------ENWSEKEAIDFASKLTKKCPDIVIVTQEIGYGLVPVDAFDRRYRELTGRICTVLAANSDQVDRVVCGIGVTIK    
188 UniRef50_UPI0001C35460 hypothetical protein ChatD1...   105     6e-22  1  22.8%   2:181   1:145     -MIFITGGAWQGKTAFAETLAVD-------------------------------FVTMESGERVSCA--GSITEKKAVPVACGRSDPFETAFERPVISGFHYFVRRLLRE--ERDVNEFIAAIGEKNPNAVITADELGCGIVPADPEERAWREAAGRAAEILAADSDAVYRMICGIAVRLK    
189 UniRef50_B8IYN2        Adenosyl cobinamide kinase/...   104     2e-21  1  29.3%  66:181 124:227     -----------------------------------------------------------------EAAQQSAPKPGVLLLDCISLWIANLL------------ACDLGQEDILCKVSALGERLAAPPLPVAVVSAETGLGLVPMSPLARTFNDVLGLANQELARACRHVVFVSCGLPLPLK    
190 UniRef50_A6CHV6        Putative uncharacterized pr...   103     3e-21  1  17.8%   2:181   1:140     -MQFITGGTFNGKSKWVRENNDSSKEWI-----KLFDADSMPQHDDH---------------------------EGTVVIEGLEYLVLSLL--------RTGRDSDSLRKAFITSFQQWKSWEDDSSNEVIWIGSDISKGIVPMNAEDRLWRDMTGWIYQDLVKHSDRVYEIWFGLPTILK    
191 UniRef50_A5ZUQ0        Putative uncharacterized pr...   101     1e-20  1  22.8%   2:181   6:129     -MKMIIGGAFQGKAAFAEKKYPE------IEWVNGADADW------------NSIQNAKGVVNFHEFIRAEMKKN--------------------------------------EDVSDLAEKLIQCNPGVLLVSDEVGYGVVPMDAFDRAYREAVGRICTKLAAYSDEVTRVVCGIGTVIK    
192 UniRef50_Q9KCH7        BH1594 protein n=1 Tax=Baci...    99     8e-20  1  21.7%   2:181   1:140     -MHFVTGGAFHGKHQWVRE--------------------------HYKLQRRSDYVVHNGFAG-AKVLPSSIEEGELVIVTGLHLYIRMLLGHEEPRTVLKHWLQDAI-------------SWEKGGKTVVLIGNEIGKGIVPVKREDREWRDLVGLCYQDIVRLAERVDLIWYGLNQQIK    
193 UniRef50_C7M3A3        Cobalbumin biosynthesis pro...    98     9e-20  1  28.1%   4:181   5:163     ---LVLGARRSGKSAWAEARAVELRIGTYLATAAAH-ALDAERLAAHRARRIGRFVTLedPGELVELVRTVP--------------------GGLLLDGLGLWVGWQLSSDHDVSSGELVAALARRSSPTIVVSDEVGWSVHPERALAQRFVDELGALNQAVAAIAAQVTLVVAGLPLRLK    
194 UniRef50_C9L8S7        Cobalamin biosynthesis prot...    98     9e-20  1  20.6%   2:181   1:126     -MKLIIGGAFQGKKEYVKEKFSLSEE-------QMTDG-------------------------------KNAEYDDIFHCTCL--------------YHFHEWVKKGLEKEW--DFENLAEKIQEKNPDLIVISNELGYGVVPIDAFDRKYRESTGRLCTQLAAKSRQVIRVVCGLGMVIK    
195 UniRef50_UPI0001972E89 hypothetical protein ClM62_...    98     1e-19  1  26.1%   2:181   1:148     -MILIVGGSHQGKSRAA---LRHFNRVNGMESSSVLDGRMME-------ERGFG--------GVEELYEALLSADVILHLE--------KLFEYLMRETENPEDFGS------AFLLQMEAREKAEGRDRVLTADEIGCGIVPLDPFERDYREREGRFCQRAAAQAREVYRILCGLEMRLK    
196 UniRef50_C4ZB11        Putative uncharacterized pr...    98     2e-19  1  17.2%   2:181   1:148     -MKLVIGGVAQGKLDYVLENMIEKTEKYDVYDCFFldNACNDKAS-----------NMEWPWDFA--------------VDDESILIIDKFHYFIRAVLEKNLPLQEYILKFMQ--------FAEENKDTIVIADEIGNGIVPLDAFERAYREQTGRAEILLAKKADEVVRVICGIGQKIK    
197 UniRef50_C0D1B0        Putative uncharacterized pr...    97     2e-19  1  27.2%   2:181   1:145     -MILVTGGTAQGKREFVERDLI--GELAGERTGGM-------------AGRPAGGR---------AVIWVDGAAAEP---DC--------FLSAPFCHNLQAFVRRIVSGEIAVDLVELTELMQKARPDRVIVTDEIGGGIVPTDPLERTWREETGRVCCRLAAAAGQVWRVNCGLGQRIK    
198 UniRef50_A8RKD7        Putative uncharacterized pr...    97     3e-19  1  23.3%   2:181   1:143     -MILVTGGSFQGKRVFVRQYLGEQN-----ADGAVWTEGAE-----------ASW---EEFMD--GRFCRDFQ----------------LFVRRVMEGSAGPSFREQKGPAMDQILEQLLEELLAGPKDRVLVTDEIGCGIVPADAFERLYREETGRLCCRIAGEADEVWRVCCGTGIRIK    
199 UniRef50_C6UMU2        Putative adenosylcobinamide...    96     4e-19  1  21.8%   3:181   1:158     --MLVLGSPKAGRSTLC-RFVSGGAAAACVVTASACG---MRRSAGHVAKRASCWHVYEECVKVAECVRAVGCLYDVVVVDGLAAWVACL---------------VALGFNAMLEVDKLLMALKAATAKVVVVST---LELASNSSlaRSYNDLLSVANQQLARKLARVYLLVCGLKLRLK    
200 UniRef50_D2YKT8        Adenosylcobalamin biosynthe...    94     2e-18  1  40.3%    2:78    3:84     -VHLILGGARSGKSSHAESFAkhSASLHYVATATALDDEMRARIAHHQARRTAEWIEHEVSLALADYLARFTKKRCGV-------------------------------------------------------------------------------------------------------    
201 UniRef50_UPI0001850D5D hypothetical protein Bcoam_...    94     3e-18  1  18.3%   2:181   1:141     -MYFITGGAFNGKIDWTKNNLVYTQNV--------------------------KWVKEEES------IFPLGGEDNSTIV------ITNL--EKRIYCMLDQVDSSKIRIIWVQMLLDLKNwlHGNNRHVLIIGNDITRGIVPMDASIRQFRDLVGWLYQDTVKYCDDVYKIWYGLPTKLK    
202 UniRef50_UPI0001744126 adenosylcobinamide kinase/a...    89     6e-17  1  41.7%    2:61    3:66     -LIFVTGGAKSGKSKFAekLNNGKQKNIYLATSLVFDEEMKEKVRLHKKRRKDEWFTVEAY------------------------------------------------------------------------------------------------------------------------    
203 UniRef50_C4IN29        Cobinamide kinase n=2 Tax=C...    89     6e-17  1  23.3%  79:181  27:134     ------------------------------------------------------------------------------VVDCldGLKAEEILMSNKPVIYNFNNLIKELLVveEKVKENIKKMIKENRKAVIISNEIGYGIVPIDKFERRYRELTGRICCEIAKESKEVHRVICGIGTIIK    
204 UniRef50_B0MDC3        Putative uncharacterized pr...    88     2e-16  1  25.0%   2:181   1:126     -MIIIIGGAFQGKKQYAE-------RVTGIPGNQMTD--------------GADCSLEEIYS-----------------CQCLY-----HFHEWVRRKLPDIKDYEQEARKIFE-----------ANPELVLIANELGCGVVPANAFDRNFRETEGRLLTCLAGMSSEVHRVVCGIGTVIK    
205 UniRef50_A4IQD6        Putative uncharacterized pr...    86     3e-16  1  18.9%   2:181   1:138     -MHFVVGGAFQGKRKWVRERYGIGDGV---------------QIVWH-----DGYQEPYGPPNGVKVAK-------TVVFEGL---------EAAIRRLPDTAEWERFFHAWKQWEDEV------AGRTVVWVGTDVTQGVVPTDPADRRWRDAVGVCYQRLAAMCCRVDRLWCGLAERLK    
206 UniRef50_B7ATE3        Putative uncharacterized pr...    84     2e-15  1  28.9%  92:181  24:113     -------------------------------------------------------------------------------------------DYDDGVVGDTDCIYNLQKAVMNEDFDSRLDEYIMLHPHCVIICDEIGSGIVPLRREDREWREKTGRVCCELANKADAVYRVFCGIGMQLK    
207 UniRef50_A9KMP1        Cobalamin biosynthesis prot...    83     3e-15  1  21.1%   2:181   1:131     -MELVIGGRASGKLEY---------------TMKV------------------------SGLAIDAVAESVIDETKQIL---------NSLQDTIREWMKEDYSSLSDEEMITKYLGRLHGYIKK-NPNCFIICDEVGLGVVPLEAIERSYREVVGRVLCELAKLSKKVHRVYYGIGAIIK    
208 UniRef50_Q2B548        Putative uncharacterized pr...    82     8e-15  1  24.1%  49:181   6:127     ------------------------------------------------AEEKASWHSAYKGVRLPEAADA---ATDCVILEGIEQWI---------REDIKRMDKDPARALWKERLDDWLRWEAgqERKLVLIGTDITKGIVPMEKEDRDWRDAAGWIFQDAAAAAERVDLIWYGISRKLK    
209 UniRef50_A6NSE5        Putative uncharacterized pr...    81     1e-14  1  16.7%   2:181   1:120     -MRLIIGGAGQGKLDYALK-------KMGLAPSAV-------------------------------ALDPAQAADKAIL------------YHLEAWVKANPAADHLAA----------LEELLTVNPGIVILCDEVGCGVVPIAREERAWREAVGRLCCALAKRADTVERIFCGIPMTLK    
210 UniRef50_C7GCH6        Cobalbumin biosynthesis enz...    81     2e-14  1  31.9% 113:181  58:126     ----------------------------------------------------------------------------------------------------------------QADVPKLTETFIKKNPDCIVICNEVGCGVVPMLKEEREYREQVGRMQVILAKSSESVERVICGIAQKIK    
211 UniRef50_B0PB89        Putative uncharacterized pr...    80     3e-14  1  16.7%   2:181   1:126     -MTLIIGGRAQGKRAYALSQ-------TGLGAAHICDGGVCP---------------------FNAAFDQPILAR-------LHLLVRRLMQAG-------------------QDARQIILNGAAAHPDLTIICDEVGCGVVPVDAFERAWREQVGRICCALAEQSARVVRVYAGIPTILK    
212 UniRef50_C4GBH4        Putative uncharacterized pr...    80     4e-14  1  20.6%   2:181   3:158     -LDLYLGGYAQGKLQYVLGKYPAAR------------AEIVE--GSHLPCRGDDLACVFEQTD---ALRIWNHFHSFV-----REMLKNRLPEHLSKLPYREQ--EKWEDLFLDECLEVIRQADRTCGKLIVISDIAGNGIVPLDPGDRIYREMLGRLQVRMAARAGHVELVTAGLGQVLK    
213 UniRef50_UPI0001C4309A hypothetical protein BpOF4_...    78     1e-13  1  23.2%  87:181  37:132     --------------------------------------------------------------------------------------ISIIFGLEHVIEQFLEQDVDHSRGLFRQWLQRLIEWEDSSPKnlYLIGCDIGKGIVPIDSRHRSLRDLVGWCYQDIVERADRVDVIWYGINQRLK    
214 UniRef50_C4Z7P5        Putative uncharacterized pr...    78     1e-13  1  33.8% 117:181  60:124     --------------------------------------------------------------------------------------------------------------------DSLIDSLYDINPEIIIICDEVGSGIVPLEKEDRIYREAVGRVLCSAVKKAVHVERVICGIGQCLK    
215 UniRef50_C0EAM7        Putative uncharacterized pr...    77     3e-13  1  34.8% 113:181  56:119     ----------------------------------------------------------------------------------------------------------------LARIDELVE-----GRDLVILCDEVGCGVVPIDPAQREWREAVGRVCCALAQKAVFVDRVQCGIATRIK    
216 UniRef50_UPI00005234FA PREDICTED: similar to RAD51...    77     3e-13  1  19.5%   5:158 105:271     ----IVGPSSSGKTQLCETFAVndQNVIYIDTAGGfgEIFKKRFSShrIRVSRCFEVSELRETLDLVRRKMSAQDevVIIDSVTSLLSTVLYNGTFVEGM----------ASLQSIGRQLNALAKDFALAVVITNDMVTG--PQDKTGQFSRkaLGRV-----------------------    
217 UniRef50_UPI0001C36F28 hypothetical protein RflaF_...    76     6e-13  1  28.1% 118:181  63:125     ---------------------------------------------------------------------------------------------------------------------AFTEKLCNASAEAIIM-DETGCGIVPIDKNDRLIREAVGRCGCIIAQNCHTVVRVCCGIPTIIK    
218 UniRef50_C7GCH4        Cobinamide kinase/cobinamid...    75     1e-12  1  32.8%    1:64    1:68     MMVVVTGASGSGKSEYAEGVaaGKGDLYYLATMRVYGEEGVRRVERHRKLrgKGFQTAECPVKV---------------------------------------------------------------------------------------------------------------------    
219 UniRef50_C7N885        Adenosyl cobinamide kinase/...    74     3e-12  1  28.7%  95:181  28:111     ----------------------------------------------------------------------------------------------DAVIDDRPALRNAQELVRHAEVEDVFPQLMEKD---LVIAEEVGSGVVPATHEDRAWRDRAGHLSIRLAEHADTVVRMVCGIPVVLK    
220 UniRef50_B1HXM7        Putative uncharacterized pr...    73     4e-12  1  28.6%  70:181   2:114     ---------------------------------------------------------------------RLYEQHDVVLVEGDLPDVaeILVIKHVEKWLMTQNLEEDEVVVQSVLTKLT-ALAQHCSLVLIVTD-MGRGVVPMEKQARLLRDTCGRLYQALFAEAEQVVRIWYGIGEQLK    
221 UniRef50_C0FSZ3        Putative uncharacterized pr...    73     5e-12  1  30.8% 117:181  46:110     --------------------------------------------------------------------------------------------------------------------EEIVLQYYKEHSDCIFICDEIGNGIVPMEKQEREYRERVGRLLIRLAGEAETVERIICGIGQKIK    
222 UniRef50_C1I2K8        Putative uncharacterized pr...    72     7e-12  1  17.8%   2:181   5:131     -LILVFGGAYNGKLSFveKFNISDEEVLTL--NNIDDLE----------------------IDFSKKVINKFQ---------------NLTYKMSLENQDPLKYILENESLFKDK---------------IIISDDICEGIVPLKKEDRIWRENTGKCLQYLSKNSKEVYRVFCGIPMVIK    
223 UniRef50_B7GHK3        CobU related cobalamine bio...    71     1e-11  1  30.3% 116:181    1:66     -------------------------------------------------------------------------------------------------------------------MNAWERWEKEKERTVVWIGCDMNQGIVPIDAHERAWRDAVGWTYQQLAHICSRVDYVWCGINEQIK    
224 UniRef50_A6LSW6        Cobalamin biosynthesis prot...    68     1e-10  1  17.2%   2:181   1:124     -MKLIFGGAYNGKLDYVKEKYKVSHEQIFF-------------------CRDENIenKEIICGLHIFVKA-----------CISNKLN-------------------PIEVLKDKMDLLENK--------IIICDEINSGIVPIEKFDRIWREETGRLLQFLAKHSSHVYRIFFGIEEELK    
225 UniRef50_B9T9J3        Putative uncharacterized pr...    68     1e-10  1  50.0%    3:54 395:450     --TLLLGGARSGKSGLAERIARESGkvVYVATSYAGDAEMSARIEHhsGRRPDR-------------------------------------------------------------------------------------------------------------------------------    
226 UniRef50_Q0STX4        Cobalamin biosynthesis prot...    66     4e-10  1  35.3% 131:181  74:124     ----------------------------------------------------------------------------------------------------------------------------------ILICDEISSGIVPLKKEERLWREETGKVLQFLSKESEEVYRIFFGIGTRLK    
227 UniRef50_UPI00016C0C9A hypothetical protein Epulo_...    61     1e-08  1  30.8% 104:181  33:105     -------------------------------------------------------------------------------------------------------EWINTSADIDAHIADILA-----TPDLVVICTEIGCGIIPLDKQERQWREAVGRAACKLAAAATQVFKLEAGIPIQIK    
228 UniRef50_D1PMC0        Cobinamide kinase/cobinamid...    59     7e-08  1  37.5% 118:181  44:107     ---------------------------------------------------------------------------------------------------------------------DLTALADELAQNEIVIATEVGGGIVPVDSDARAAREAAGRFNCLLAARADIVVRVFYGLPLVLK    
229 UniRef50_C7H9A2        Adenosylcobalamin biosynthe...    58     2e-07  1  34.7% 107:181   25:99     ----------------------------------------------------------------------------------------------------------AEVQALAAEAEDLEKLAEELSAYDIVMATEVGGGVVPMDAGERAAREAAGRLACLLAARAGCVVQMFCGIPTVLK    
230 UniRef50_A4J1U0        Putative uncharacterized pr...    42     0.008  1  14.2%   5:131  19:145     ----IAGPAGSGKSFSALQMAFggGPVAMIDTERGSGELYC-----HLGEYDVC--TLEAPFTPEKYVeaEAAGYGVIIIDSLtaWatGGVLDIHGYAADKSGNSWTAWRQVTPRHNDLVDALLQSKCHII--------------------------------------------------    
231 UniRef50_Q2T972        Excinuclease ABC, subunit A...    42     0.009  1  24.5%    2:54  79:131     -MTVVTGPSGSGKSSLVFDTLYAEGQRRYVETFSAYARQFLDRMDRPQVERVDG-------------------------------------------------------------------------------------------------------------------------------    
232 UniRef50_Q0UCD3        Putative uncharacterized pr...    41     0.019  1  28.1%    2:58 473:531     -IILLHGPPGSGKTSTAETIAAYTRRPLYSITCggTDPEIVEKNLLEHTRRADQWGCV---------------------------------------------------------------------------------------------------------------------------    
233 UniRef50_Q67MD2        DNA repair exonuclease n=1 ...    41     0.023  1  14.0%  90:175    2:83     -----------------------------------------------------------------------------------------RILHTADWHLGRTLEGRSRQEEHEAFVDELCAMVREERIDLVLIAGDVFDTGNPSAAAEELYCDALAR----LGENGRRAVVVIAG------    
234 UniRef50_B5HUD0        ATPase associated with vari...    40     0.027  1  17.3%   4:136  74:217     ---LVLGPPGSGKSALAPNVARLMRFRYyvVTARTEPHDLLWREEAFRQLNDATQGTLQDPGslWKALdaMDEEGPTALRDRPAVVLIDEIDKADPDVPDALLDPLNNLRFVGPDRRTVTAAENTGAPLVVITSNE---------------------------------------------    
235 UniRef50_C7R5K9        AAA ATPase n=1 Tax=Jonesia ...    40     0.034  1  21.1%   2:124 267:378     -VVLVSGGPGSGKSVIALTLLGELARRGYpaTGSRSFTQTLRKVAGH---RKPTVQTLFKYFN--SFIDAEKNSVEVLILD-----EAHRL----REKSVNRYTPKSLRENARAQVDELLDTAR---------------------------------------------------------    
236 UniRef50_Q01CJ5        TRNA isopentenyl transferas...    40     0.041  1  19.4%   2:104  33:149     -VVVIVGPTGSGKTRLAIDLARALgrALPICTARVRDDETRG-VRHHLleQGDSFDVREFVDRAGTIVREVVGEGRSVVVAGGTNYYAQALVSDSLVDLSDGEN-----------------------------------------------------------------------------    
237 UniRef50_A1WZ98        UvrA family protein n=2 Tax...    39     0.082  1  26.4%    2:54   27:79     -LIVVTGVSGSGKSSLAFDTVYAEGQRRYVETFSAYARQFLERMDRPHVERIDG-------------------------------------------------------------------------------------------------------------------------------    
    consensus/100%                                                                                      .....................................................................................................................................................................................    
    consensus/90%                                                                                       ......G...tuc...s................................................................................................................hhhlst-h..s..........ahc..G.h...hst.st.s..h..G....h.    
    consensus/80%                                                                                       ...hlhGustuGKothu.thh.t...hhhlss....s.th..+h..H...Rs.th.hhE...th.t.h.........hlh-sht.hh...h........................h.thht.h.t....hlhVssEls.uhls.t..sc.ahc.hG.hpp.lut.sptlh.hhtGhsh.l+    
    consensus/70%                                                                                        .hllhGGstSGKSthAcphh.t.t.hhYlATs.shDt-httRlthHptpRstta.shEt.hpltthl.t....ttslll-sls.hhsp.h....................h.tthtthhthhtt.sttlllVosElGhGllP.st.sRhat-hhGthsptlAt.uspVhhshsGlsh.lK    

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown